Columns: General -- Sales -- Acquisition -- WAC
OSHPD ID | Manufacturer Name | Date Reported | Description | Acquisition Date | Acquired From | Acquisition Price | Price Comment |
---|---|---|---|---|---|---|---|
Rx0000077 | AbbVie | 04/29/2024 | CREON 12000USP DELAYED-RELEASE 100CAP | ||||
Rx0000077 | AbbVie | 04/29/2024 | CREON 12000USP DELAYED-RELEASE 250CAP | ||||
Rx0000077 | AbbVie | 04/29/2024 | CREON 24000USP DELAYED-RELEASE 100CAP | ||||
Rx0000077 | AbbVie | 04/29/2024 | CREON 24000USP DELAYED-RELEASE 250CAP | ||||
Rx0000077 | AbbVie | 04/29/2024 | CREON 3000USP DELAYED-RELEASE 70CAP | ||||
Rx0000077 | AbbVie | 04/29/2024 | CREON 36000USP DELAYED-RELEASE 100CAP | ||||
Rx0000077 | AbbVie | 04/29/2024 | CREON 36000USP DELAYED-RELEASE 250CAP | ||||
Rx0000077 | AbbVie | 04/29/2024 | CREON 6000USP DELAYED-RELEASE 100CAP | ||||
Rx0000077 | AbbVie | 04/29/2024 | IMBRUVICA 140 mg Capsules, 120-count | ||||
Rx0000077 | AbbVie | 04/29/2024 | IMBRUVICA 140 mg Tablets, 28-count | ||||
Rx0000077 | AbbVie | 04/29/2024 | IMBRUVICA 280 mg Tablets, 28-count | ||||
Rx0000077 | AbbVie | 04/29/2024 | IMBRUVICA 420 mg Tablets, 28-count | ||||
Rx0000077 | AbbVie | 04/29/2024 | IMBRUVICA 70 mg Capsules, 28-count | ||||
Rx0000077 | AbbVie | 04/29/2024 | IMBRUVICA140 mg Capsules, 90-count | ||||
Rx0000077 | AbbVie | 04/29/2024 | ORIAHNN CAPSULES 300MG/1MG/0.5MG; 4x14 | ||||
Rx0000077 | AbbVie | 04/29/2024 | ORILISSA 150MG TABS, 4X7 PACK | ||||
Rx0000077 | AbbVie | 04/29/2024 | ORILISSA 200MG TABS, 4X14 PACK | ||||
Rx0000077 | AbbVie | 04/29/2024 | RINVOQ 15MG 30 DAY BOTTLE | ||||
Rx0000077 | AbbVie | 04/29/2024 | SKYRIZI INJ 150MG/ML SINGLE-DOSE PEN | ||||
Rx0000077 | AbbVie | 04/29/2024 | SKYRIZI INJ 150MG/ML SINGLE-DOSE PREFILLED SYRINGE | ||||
Rx0000077 | AbbVie | 04/29/2024 | VENCLEXTA 100MG BOTTLE 180 TABLETS | ||||
Rx0000077 | AbbVie | 10/29/2024 | VENCLEXTA 100MG BOTTLE 180 TABLETS | ||||
Rx0000077 | AbbVie | 04/29/2024 | VENCLEXTA 100MG BOTTLE, 120 TABLETS | ||||
Rx0000077 | AbbVie | 10/29/2024 | VENCLEXTA 100MG BOTTLE, 120 TABLETS | ||||
Rx0000077 | AbbVie | 04/29/2024 | VENCLEXTA 100MG UNIT DOSE, 1 TABLET | ||||
Rx0000077 | AbbVie | 10/29/2024 | VENCLEXTA 100MG UNIT DOSE, 1 TABLET | ||||
Rx0000077 | AbbVie | 04/29/2024 | VENCLEXTA 10MG UNIT DOSE, 2 TABLETS | ||||
Rx0000077 | AbbVie | 10/29/2024 | VENCLEXTA 10MG UNIT DOSE, 2 TABLETS | ||||
Rx0000077 | AbbVie | 04/29/2024 | VENCLEXTA 10MG WALLET, 2 TABLETS X 7 | ||||
Rx0000077 | AbbVie | 10/29/2024 | VENCLEXTA 10MG WALLET, 2 TABLETS X 7 | ||||
Rx0000077 | AbbVie | 04/29/2024 | VENCLEXTA 50MG UNIT DOSE, 1 TABLET | ||||
Rx0000077 | AbbVie | 10/29/2024 | VENCLEXTA 50MG UNIT DOSE, 1 TABLET | ||||
Rx0000077 | AbbVie | 04/29/2024 | VENCLEXTA 50MG WALLET, 1 TABLET X 7 | ||||
Rx0000077 | AbbVie | 10/29/2024 | VENCLEXTA 50MG WALLET, 1 TABLET X 7 | ||||
Rx0000077 | AbbVie | 04/29/2024 | VENCLEXTA START PACK, 4X7 DAY WALLET | ||||
Rx0000077 | AbbVie | 10/29/2024 | VENCLEXTA START PACK, 4X7 DAY WALLET | ||||
Rx0000021 | Acorda Therapeutics, Inc. | 04/05/2024 | Ampyra Oral Tablet Extended Release 12 Hour 10 MG Package Size 60 - 1 Bottle | ||||
Rx0000021 | Acorda Therapeutics, Inc. | 04/05/2024 | Inbrija Inhalation Capsule 42 MG Package Size 60 - 1 Box | ||||
Rx0000251 | Actelion Pharmaceuticals US, Inc | 04/26/2024 | OPSUMIT® (macitentan)Strength:10 mg Package Size:15 Form:Tablet | ||||
Rx0000251 | Actelion Pharmaceuticals US, Inc | 04/26/2024 | OPSUMIT® (macitentan)Strength:10 mg Package Size:30 Form:Tablet | ||||
Rx0000251 | Actelion Pharmaceuticals US, Inc | 04/26/2024 | UPTRAVI® (selexipag) Strength:1000 mcg Package Size:60 Form:Tablet | ||||
Rx0000251 | Actelion Pharmaceuticals US, Inc | 04/26/2024 | UPTRAVI® (selexipag) Strength:1200 mcg Package Size:60 Form:Tablet | ||||
Rx0000251 | Actelion Pharmaceuticals US, Inc | 04/26/2024 | UPTRAVI® (selexipag) Strength:1400 mcg Package Size:60 Form:Tablet | ||||
Rx0000251 | Actelion Pharmaceuticals US, Inc | 04/26/2024 | UPTRAVI® (selexipag) Strength:1600 mcg Package Size:60 Form:Tablet | ||||
Rx0000251 | Actelion Pharmaceuticals US, Inc | 04/26/2024 | UPTRAVI® (selexipag) Strength:1800mcg Package Size:1 Form:Vial | ||||
Rx0000251 | Actelion Pharmaceuticals US, Inc | 04/26/2024 | UPTRAVI® (selexipag) Strength:200 mcg Package Size:140 Form:Tablet | ||||
Rx0000251 | Actelion Pharmaceuticals US, Inc | 04/26/2024 | UPTRAVI® (selexipag) Strength:200 mcg Package Size:60 Form:Tablet | ||||
Rx0000251 | Actelion Pharmaceuticals US, Inc | 04/26/2024 | UPTRAVI® (selexipag) Strength:200+800 mcg Package Size:200 Form:Tablet | ||||
Rx0000251 | Actelion Pharmaceuticals US, Inc | 04/26/2024 | UPTRAVI® (selexipag) Strength:400 mcg Package Size:60 Form:Tablet | ||||
Rx0000251 | Actelion Pharmaceuticals US, Inc | 04/26/2024 | UPTRAVI® (selexipag) Strength:600 mcg Package Size:60 Form:Tablet | ||||
Rx0000251 | Actelion Pharmaceuticals US, Inc | 04/26/2024 | UPTRAVI® (selexipag) Strength:800 mcg Package Size:60 Form:Tablet | ||||
Rx0000222 | Aimmune Therapeutics | 07/24/2024 | PALFORZIA - Capsule - 100mg - 2 Capsules per blister pack - 30 capsules per blister pack | ||||
Rx0000222 | Aimmune Therapeutics | 07/24/2024 | PALFORZIA - Capsule - 1mg - 3 Capsules per blister pack - 45 capsules per blister pack | ||||
Rx0000222 | Aimmune Therapeutics | 07/24/2024 | PALFORZIA - Capsule - 1mg - 6 Capsules per blister pack - 90 capsules per blister pack | ||||
Rx0000222 | Aimmune Therapeutics | 07/24/2024 | PALFORZIA - Capsule - 1mg-3 & 10mg-1 Capsules per blister pack - 45 capsules per blister pack | ||||
Rx0000222 | Aimmune Therapeutics | 07/24/2024 | PALFORZIA - Capsule - 20mg - 1 Capsule per blister pack - 15 capsules per blister pack | ||||
Rx0000222 | Aimmune Therapeutics | 07/24/2024 | PALFORZIA - Capsule - 20mg - 2 Capsules per blister pack - 30 capsules per blister pack | ||||
Rx0000222 | Aimmune Therapeutics | 07/24/2024 | PALFORZIA - Capsule - 20mg - 4 Capsules per blister pack - 60 capsules per blister pack | ||||
Rx0000222 | Aimmune Therapeutics | 07/24/2024 | PALFORZIA - Capsule - 20mg-1 & 100mg - 1 Capsules per blister pack - 30 capsules per blister pack | ||||
Rx0000222 | Aimmune Therapeutics | 07/24/2024 | PALFORZIA - Capsule - 20mg-2 & 100mg - 2 Capsules per blister pack - 60 capsules per blister pack | ||||
Rx0000222 | Aimmune Therapeutics | 07/24/2024 | PALFORZIA - Capsule - 20mg-3 & 100mg - 1 Capsules per blister pack - 60 capsules per blister pack | ||||
Rx0000222 | Aimmune Therapeutics | 07/24/2024 | PALFORZIA - Sachet - 300mg - 15 Sachet | ||||
Rx0000222 | Aimmune Therapeutics | 07/24/2024 | PALFORZIA - Sachet - 300mg - 30 Sachet | ||||
Rx0000400 | AkaRx, Inc., a Sobi Company | 04/12/2024 | DOPTELET, 1 BLISTER PACK in 1 CARTON > 10 TABLET, EQ 20MG BASE | ||||
Rx0000400 | AkaRx, Inc., a Sobi Company | 04/12/2024 | DOPTELET, 1 BLISTER PACK in 1 CARTON > 15 TABLET, EQ 20MG BASE | ||||
Rx0000400 | AkaRx, Inc., a Sobi Company | 04/12/2024 | DOPTELET, 2 BLISTER PACK in 1 CARTON / 15 TABLET, FILM COATED in 1 BLISTER PACK, EQ 20MG BASE | ||||
Rx0000417 | Akebia Therapeutics, Inc. | 03/31/2024 | Auryxia (Ferric Citrate) 210 mg, 200 Tablets per Bottle | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | Alcaine Ophthalmic Solution 0.5 % 15ml per package | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | BSS Plus Intraocular Solution 500ml per package, Flex cont | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | BSS Plus Intraocular Solution 500ml per package, Flex cont | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | BSS Plus Intraocular Solution 500ml per package, Glass Cont | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | BSS Plus Intraocular Solution 500ml per package, Glass Cont | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | Cyclogyl Ophthalmic Solution 0.5 % 15ml per package | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | Cyclogyl Ophthalmic Solution 1 % 5ml per package | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | Cyclogyl Ophthalmic Solution 2 % 15ml per package | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | Cyclogyl Ophthalmic Solution 2 % 2ml per package | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | Cyclogyl Ophthalmic Solution 2 % 5ml per package | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | Cyclomydril Ophthalmic Solution 0.2-1 % 5ml per package | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | Isopto Atropine Ophthalmic Solution 1 % 5ml per package | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | Miostat Intraocular Solution 0.01 % 12 vials per package | ||||
Rx0000246 | Alcon Laboratories Inc | 04/30/2024 | Mydriacyl Ophthalmic Solution 1 % 15ml per package | ||||
Rx0000272 | Alexion Pharmaceuticals | 04/30/2024 | CAPSULE 10MG 28 COUNT | ||||
Rx0000272 | Alexion Pharmaceuticals | 04/30/2024 | CAPSULE 10MG 60 COUNT | ||||
Rx0000272 | Alexion Pharmaceuticals | 04/30/2024 | CAPSULE 25MG 28 COUNT | ||||
Rx0000272 | Alexion Pharmaceuticals | 04/30/2024 | CAPSULE 25MG 60 COUNT | ||||
Rx0000459 | AltaThera Pharmaceuticals LLC | 03/31/2024 | Sotalol hydrochloride - Injection: 10-mL vial containing sotalol hydrochloride 150 mg | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Alfuzosin HCl Tab ER 24HR 10 MG, 100 Each, Bottle | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Alitretinoin Gel 0.1%, 60 GM, Unit-of-Use, Tube | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Digoxin Tab 125 MCG (0.125 MG), 100 Each, Bottle | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Digoxin Tab 125 MCG (0.125 MG), 100 Each, Unit-Dose, Box | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Digoxin Tab 250 MCG (0.25 MG), 100 Each, Bottle | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Digoxin Tab 62.5 MCG (0.0625 MG), 100 Each, Bottle | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Donnatal Oral Elixir 16.2 MG/5ML 16.2-0.1037-0.0194-0.0065 MG/5ML, 480 ML, Bottle | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Donnatal Oral Elixir 16.2 MG/5ML PB-Hyoscy-Atrop-Scopol Elix 16.2-0.1037-0.0194-0.0065 MG/5ML, 120 ML, Bottle | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | PB-Hyoscy-Atrop-Scopol Elix 16.2-0.1037-0.0194-0.0065 MG/5ML, 120 ML, Bottle | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | PB-Hyoscy-Atrop-Scopol Elix 16.2-0.1037-0.0194-0.0065 MG/5ML, 480 ML, Bottle | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | PB-Hyoscy-Atrop-Scopol Tab 16.2-0.1037-0.0194-0.0065 MG, 100 Each, Bottle | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Prednisolone Sod Phos Orally Disintegr Tab 10 MG (Base Eq), 12 Each, Unit-Dose, Box | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Prednisolone Sod Phos Orally Disintegr Tab 15 MG (Base Eq), 12 Each, Unit-Dose, Box | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Prednisolone Sod Phos Orally Disintegr Tab 30 MG (Base Eq), 12 Each, Unit-Dose, Box | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Tranylcypromine Sulfate Tab 10 MG, 100 Each, Bottle | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Triamterene Cap 100 MG, 100 Each, Bottle | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Triamterene Cap 50 MG, 100 Each, Bottle | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Zonisamide Cap 100 MG, 100 Each, Bottle | ||||
Rx0000436 | Amdipharm Limited | 07/25/2024 | Zonisamide Cap 25 MG, 100 Each, Bottle | ||||
Rx0000231 | American Health Packaging | 05/10/2024 | DOXYCYCLINE TABLET 100MG 30UD | ||||
Rx0000231 | American Health Packaging | 05/10/2024 | MESALAMINE DR CAP 400MG 20UD | ||||
Rx0000231 | American Health Packaging | 06/17/2024 | METHYLPHENIDATE HCL TABLET CII 5MG 30UD | ||||
Rx0000231 | American Health Packaging | 05/10/2024 | RIFAMPIN CAPS 150MG 30UD | ||||
Rx0000231 | American Health Packaging | 05/10/2024 | RIFAMPIN CAPSULE 300MG 100UD | ||||
Rx0000128 | American Regent | 04/18/2024 | ACETYLCYSTEINE SOLUTION 10%, 4ML, PKG OF 25 | ||||
Rx0000128 | American Regent | 10/15/2024 | ACETYLCYSTEINE SOLUTION 10%, 4ML, PKG OF 25 | ||||
Rx0000128 | American Regent | 04/02/2024 | Caffeine & Sodium Benzoate, 250mg/ml 2mL SDV, 10pk | ||||
Rx0000128 | American Regent | 10/15/2024 | Caffeine & Sodium Benzoate, 250mg/ml 2mL SDV, 10pk | ||||
Rx0000128 | American Regent | 10/15/2024 | Drug Product Description HYDROXYZINE HCL, 50MG/ML, 1ML SDV, PKG. OF 25 | ||||
Rx0000128 | American Regent | 04/18/2024 | HYDROXYZINE HCL, 25MG/ML, 1ML SDV, PKG. OF 25 | ||||
Rx0000128 | American Regent | 10/15/2024 | HYDROXYZINE HCL, 25MG/ML, 1ML SDV, PKG. OF 25 | ||||
Rx0000128 | American Regent | 04/18/2024 | HYDROXYZINE HCL, 50MG/ML, 1ML SDV, PKG. OF 25 | ||||
Rx0000128 | American Regent | 10/15/2024 | Injectafer Intravenous Solution 750 MG/15ML | ||||
Rx0000128 | American Regent | 10/15/2024 | MULTRYS (TRACE ELEMENTS INJECTION 4, USP, PKG. OF 25 | ||||
Rx0000128 | American Regent | 10/15/2024 | Tralement (TRACE ELEMENTS INJECTION 4, USP, PKG. OF 25 | ||||
Rx0000069 | Amgen | 04/30/2024 | Aimovig, 140 mg/mL single-dose prefilled SureClick autoinjector | ||||
Rx0000069 | Amgen | 04/30/2024 | Aimovig, 70 mg/mL single-dose prefilled SureClick autoinjector | ||||
Rx0000069 | Amgen | 04/30/2024 | Blincyto, 35 mcg lyophilized vial, 1 pk | ||||
Rx0000069 | Amgen | 04/30/2024 | Corlanor, 5mg oral solution AMP, 28 pk | ||||
Rx0000069 | Amgen | 04/30/2024 | Corlanor, 5mg tablet, 60 pk | ||||
Rx0000069 | Amgen | 04/30/2024 | Corlanor, 7.5mg tablet, 60 pk | ||||
Rx0000069 | Amgen | 04/30/2024 | Enbrel Mini, 50mg/mL, Cartridge (ML), 1 pack | ||||
Rx0000069 | Amgen | 09/20/2024 | Enbrel Mini, 50mg/mL, Cartridge (ML), 1 pack | ||||
Rx0000069 | Amgen | 04/30/2024 | Enbrel Mini, 50mg/mL, Cartridge (ML), 4 pack | ||||
Rx0000069 | Amgen | 09/20/2024 | Enbrel Mini, 50mg/mL, Cartridge (ML), 4 pack | ||||
Rx0000069 | Amgen | 04/30/2024 | Enbrel Sureclick, 50mg/mL, Pen Injector (ML), 1 pack | ||||
Rx0000069 | Amgen | 09/20/2024 | Enbrel Sureclick, 50mg/mL, Pen Injector (ML), 1 pack | ||||
Rx0000069 | Amgen | 04/30/2024 | Enbrel Sureclick, 50mg/mL, Pen Injector (ML), 4 pack | ||||
Rx0000069 | Amgen | 09/20/2024 | Enbrel Sureclick, 50mg/mL, Pen Injector (ML), 4 pack | ||||
Rx0000069 | Amgen | 04/30/2024 | Enbrel, 25mg (1 mL), Vial (EA), 4 pack | ||||
Rx0000069 | Amgen | 04/30/2024 | Enbrel, 25mg (1mL), Vial (EA), 1 pack | ||||
Rx0000069 | Amgen | 04/30/2024 | Enbrel, 25mg/0.5mL, Syringe (ML), 1 pack | ||||
Rx0000069 | Amgen | 09/20/2024 | Enbrel, 25mg/0.5mL, Syringe (ML), 1 pack | ||||
Rx0000069 | Amgen | 04/30/2024 | Enbrel, 25mg/0.5mL, Syringe (ML), 4 pack | ||||
Rx0000069 | Amgen | 09/20/2024 | Enbrel, 25mg/0.5mL, Syringe (ML), 4 pack | ||||
Rx0000069 | Amgen | 04/30/2024 | Enbrel, 25mg/0.5mL, Vial (EA), 1 pack | ||||
Rx0000069 | Amgen | 09/20/2024 | Enbrel, 25mg/0.5mL, Vial (EA), 1 pack | ||||
Rx0000069 | Amgen | 04/30/2024 | Enbrel, 25mg/0.5mL, Vial (EA), 4 pack | ||||
Rx0000069 | Amgen | 09/20/2024 | Enbrel, 25mg/0.5mL, Vial (EA), 4 pack | ||||
Rx0000069 | Amgen | 04/30/2024 | Enbrel, 50mg/mL, Syringe (ML), 1 pack | ||||
Rx0000069 | Amgen | 09/20/2024 | Enbrel, 50mg/mL, Syringe (ML), 1 pack | ||||
Rx0000069 | Amgen | 04/30/2024 | Enbrel, 50mg/mL, Syringe (ML), 4 pack | ||||
Rx0000069 | Amgen | 09/20/2024 | Enbrel, 50mg/mL, Syringe (ML), 4 pack | ||||
Rx0000069 | Amgen | 04/30/2024 | Evenity, 105mg, 1.17mL prefilled syringe, 1 pk | ||||
Rx0000069 | Amgen | 07/25/2024 | Evenity, 105mg, 1.17mL prefilled syringe, 1 pk | ||||
Rx0000069 | Amgen | 04/30/2024 | Evenity, 105mg, 1.17mL prefilled syringe, 2 pk | ||||
Rx0000069 | Amgen | 07/25/2024 | Evenity, 105mg, 1.17mL prefilled syringe, 2 pk | ||||
Rx0000069 | Amgen | 04/30/2024 | Imlygic, 106 (1 million) PFU/mL (1.0 mL) single-use vial | ||||
Rx0000069 | Amgen | 04/30/2024 | Imlygic, 108 (100 million) PFU/mL (1.0 mL) single-use vial | ||||
Rx0000069 | Amgen | 04/30/2024 | Kyprolis, 10 mg (2mg/mL) lyophilized vial, 1 pk | ||||
Rx0000069 | Amgen | 07/25/2024 | Kyprolis, 10 mg (2mg/mL) lyophilized vial, 1 pk | ||||
Rx0000069 | Amgen | 04/30/2024 | Kyprolis, 30 mg (2mg/mL) lyophilized vial, 1 pk | ||||
Rx0000069 | Amgen | 07/25/2024 | Kyprolis, 30 mg (2mg/mL) lyophilized vial, 1 pk | ||||
Rx0000069 | Amgen | 04/30/2024 | Kyprolis, 60 mg lyophilized vial, 1 pk | ||||
Rx0000069 | Amgen | 07/25/2024 | Kyprolis, 60 mg lyophilized vial, 1 pk | ||||
Rx0000069 | Amgen | 04/30/2024 | Lumakras, 120mg Tablet, 240 pack | ||||
Rx0000069 | Amgen | 04/30/2024 | Lumakras, 320mg Tablet, 90 pack | ||||
Rx0000069 | Amgen | 04/30/2024 | Nplate, 125 mcg, 0.25mL (500 mcg/mL) single-use vial | ||||
Rx0000069 | Amgen | 07/25/2024 | Nplate, 125 mcg, 0.25mL (500 mcg/mL) single-use vial | ||||
Rx0000069 | Amgen | 04/30/2024 | Nplate, 250 mcg, 0.5mL (500 mcg/mL) single-use vial | ||||
Rx0000069 | Amgen | 07/25/2024 | Nplate, 250 mcg, 0.5mL (500 mcg/mL) single-use vial | ||||
Rx0000069 | Amgen | 04/30/2024 | Nplate, 500 mcg, 1.0mL (500 mcg/mL) single-use vial | ||||
Rx0000069 | Amgen | 07/25/2024 | Nplate, 500 mcg, 1.0mL (500 mcg/mL) single-use vial | ||||
Rx0000069 | Amgen | 04/30/2024 | Otezla, 10mg (4)-20mg (4)-30g (47), Tablet Dose Pack, 55 pack | 11/21/2019 | Celgene | 13400000000 | |
Rx0000069 | Amgen | 07/25/2024 | Otezla, 10mg (4)-20mg (4)-30g (47), Tablet Dose Pack, 55 pack | 11/21/2019 | Celgene | 13400000000 | |
Rx0000069 | Amgen | 04/30/2024 | Otezla, 30mg, Tablet, 60 pack | 11/21/2019 | Celgene | 13400000000 | |
Rx0000069 | Amgen | 07/25/2024 | Otezla, 30mg, Tablet, 60 pack | 11/21/2019 | Celgene | 13400000000 | |
Rx0000069 | Amgen | 04/30/2024 | Parsabiv, 10 mg/2 mL single-dose vial, 1 pack | ||||
Rx0000069 | Amgen | 04/30/2024 | Parsabiv, 10 mg/2 mL single-dose vial, 10 pack | ||||
Rx0000069 | Amgen | 04/30/2024 | Parsabiv, 2.5 mg/0.5 mL single-dose vial, 1 pack | ||||
Rx0000069 | Amgen | 04/30/2024 | Parsabiv, 2.5 mg/0.5 mL single-dose vial, 10 pack | ||||
Rx0000069 | Amgen | 04/30/2024 | Parsabiv, 5 mg/1 mL single-dose vial, 1 pack | ||||
Rx0000069 | Amgen | 04/30/2024 | Parsabiv, 5 mg/1 mL single-dose vial, 10 pack | ||||
Rx0000069 | Amgen | 04/30/2024 | Prolia, 60 mg, 1.0mL (60 mg/mL) prefilled syringe | ||||
Rx0000069 | Amgen | 07/25/2024 | Prolia, 60 mg, 1.0mL (60 mg/mL) prefilled syringe | ||||
Rx0000069 | Amgen | 04/30/2024 | Repatha, 140 mg, 1.0 mL (140 mg/mL) autoinjector, 2 pack | ||||
Rx0000069 | Amgen | 04/30/2024 | Repatha, 140 mg, 1.0 mL (140 mg/mL) prefilled syringe | ||||
Rx0000069 | Amgen | 04/30/2024 | Repatha, 420 mg, 3.5 mL (120 mg/mL) Pushtronex system | ||||
Rx0000069 | Amgen | 04/30/2024 | Vectibix, 100 mg, 5 mL (20 mg/mL) single-use vial | ||||
Rx0000069 | Amgen | 07/25/2024 | Vectibix, 100 mg, 5 mL (20 mg/mL) single-use vial | ||||
Rx0000069 | Amgen | 04/30/2024 | Vectibix, 400 mg, 20 mL (20 mg/mL) single-use vial | ||||
Rx0000069 | Amgen | 07/25/2024 | Vectibix, 400 mg, 20 mL (20 mg/mL) single-use vial | ||||
Rx0000069 | Amgen | 04/30/2024 | Xgeva, 120 mg /1.7 mL (70 mg/mL) single-use vial | ||||
Rx0000069 | Amgen | 07/25/2024 | Xgeva, 120 mg /1.7 mL (70 mg/mL) single-use vial | ||||
Rx0000122 | Amneal Pharmaceuticals | 07/02/2024 | Budesonide Inhalation Suspension 0.25 MG/2ML 30 ampules | ||||
Rx0000122 | Amneal Pharmaceuticals | 07/02/2024 | Budesonide Inhalation Suspension 0.5 MG/2ML 30 ampules | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 03/31/2024 | BiDil 20mg/37.5mg 90 (Isosorbide Dinitrate/Hydralazine HCl Tablets) | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 03/31/2024 | EDARBI 40mg (azilsartan medoxomil) 30 tablets | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 03/31/2024 | EDARBI 80mg (azilsartan medoxomil) 30 tablets | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 03/31/2024 | EDARBYCLOR 40mg/12.5mg (azilsartan medoxomil / chlorthalidone) 30 tablets | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 03/31/2024 | EDARBYCLOR 40mg/25mg (azilsartan medoxomil / chlorthalidone) 30 tablets | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 03/31/2024 | Gliadel 7.7mg 8 Implant Wafers | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 03/31/2024 | HORIZANT 300MG (gabapentin enacarbil) 30 extended-release tablets | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 03/31/2024 | HORIZANT 600MG (gabapentin enacarbil) 30 extended-release tablets | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 03/31/2024 | Nymalize 30mg/5mL prefilled oral syringe 12x5 ml | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 03/31/2024 | Nymalize 60mg/10ml Oral Solution 237ml 8oz | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 03/31/2024 | Nymalize 60mg/10mL prefilled oral syringe 12x10ml | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 03/31/2024 | SOTYLIZE 5mg/ml (sotalol hydrochloride) oral solution 250 ml | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 03/31/2024 | SOTYLIZE 5mg/ml (sotalol hydrochloride) oral solution 480ml | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 06/11/2024 | ZENZEDI C-II 10mg, 30 (Dextroamphetamine Sulfate Tablets) | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 06/11/2024 | ZENZEDI C-II 15mg, 30 (Dextroamphetamine Sulfate Tablets) | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 06/11/2024 | ZENZEDI C-II 2.5mg, 30 (Dextroamphetamine Sulfate Tablets) | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 06/11/2024 | ZENZEDI C-II 20mg, 30 (Dextroamphetamine Sulfate Tablets) | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 06/11/2024 | ZENZEDI C-II 30mg, 30 (Dextroamphetamine Sulfate Tablets) | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 06/11/2024 | ZENZEDI C-II 5mg, 30 (Dextroamphetamine Sulfate Tablets) | ||||
Rx0000132 | Arbor Pharmaceuticals, LLC | 06/11/2024 | ZENZEDI C-II 7.5mg, 30 (Dextroamphetamine Sulfate Tablets) | ||||
Rx0000359 | Ardelyx, Inc. | 04/23/2024 | Ibsrela Oral Tablet 50 MG, 60 Each, Unit-of-Use, Bottle | ||||
Rx0000048 | Astellas Pharma US, Inc. | 03/31/2024 | Cresemba, 186 mg / 14 capsules per blister pack | ||||
Rx0000048 | Astellas Pharma US, Inc. | 03/31/2024 | Cresemba, 372 mg / 1 vial | ||||
Rx0000048 | Astellas Pharma US, Inc. | 03/31/2024 | Xtandi, 40 mg / 120 capsules per bottle | ||||
Rx0000048 | Astellas Pharma US, Inc. | 03/31/2024 | Xtandi, 40 mg / 120 tablets per bottle | ||||
Rx0000048 | Astellas Pharma US, Inc. | 03/31/2024 | Xtandi, 80 mg / 60 tablets per bottle | ||||
Rx0000015 | AstraZeneca | 07/25/2024 | LYNPARZA 120ct TABLET 100MG | ||||
Rx0000015 | AstraZeneca | 07/25/2024 | LYNPARZA 120ct TABLET 150MG | ||||
Rx0000015 | AstraZeneca | 07/25/2024 | LYNPARZA 60ct TABLET 100MG | ||||
Rx0000015 | AstraZeneca | 07/25/2024 | LYNPARZA 60ct TABLET 150MG | ||||
Rx0000354 | AVEO Pharmaceuticals, Inc. | 04/24/2024 | Fotivda Oral Capsule 0.89 MG, 21 Each, Bottle | ||||
Rx0000354 | AVEO Pharmaceuticals, Inc. | 10/25/2024 | Fotivda Oral Capsule 0.89 MG, 21 Each, Bottle | ||||
Rx0000354 | AVEO Pharmaceuticals, Inc. | 04/24/2024 | Fotivda Oral Capsule 1.34 MG, 21 Each, Bottle | ||||
Rx0000354 | AVEO Pharmaceuticals, Inc. | 10/25/2024 | Fotivda Oral Capsule 1.34 MG, 21 Each, Bottle | ||||
Rx0000277 | Avion Pharmaceuticals, LLC | 04/23/2024 | Balcoltra Oral Tablet 0.1 - 20 mg/mcg pkg, size 1 - Insert | ||||
Rx0000277 | Avion Pharmaceuticals, LLC | 04/23/2024 | Balcoltra Oral Tablet 0.1 - 20 mg/mcg pkg, size 3 | ||||
Rx0000108 | AvKare | 07/31/2024 | Ergocalciferol (vitamin D2) Capsule 1,250 mcg 100ct | ||||
Rx0000108 | AvKare | 07/31/2024 | Letrozole Tablet 2.5mg 90ct | ||||
Rx0000108 | AvKare | 07/31/2024 | losartan potassium/hydrochlorothiazide tablet 100 mg-12.5 mg 90ct | ||||
Rx0000108 | AvKare | 07/31/2024 | losartan potassium/hydrochlorothiazide tablet 100 mg-25 mg 90ct | ||||
Rx0000108 | AvKare | 07/31/2024 | Losartan potassium/hydrochlorothiazide tablet 50 mg-12.5 mg 90ct | ||||
Rx0000108 | AvKare | 07/31/2024 | Progesterone Capsule 100mg 100ct | ||||
Rx0000108 | AvKare | 07/31/2024 | Progesterone Capsule 200mg 100ct | ||||
Rx0000108 | AvKare | 07/31/2024 | Sulfamethoxazole/trimethoprim tablet 400 mg-80 mg 100ct | ||||
Rx0000108 | AvKare | 07/31/2024 | Sulfamethoxazole/trimethoprim tablet 400 mg-80 mg 500ct | ||||
Rx0000108 | AvKare | 07/31/2024 | Sulfamethoxazole/trimethoprim tablet 800 mg-160 mg 100ct | ||||
Rx0000108 | AvKare | 07/31/2024 | Sulfamethoxazole/trimethoprim tablet 800 mg-160 mg 500ct | ||||
Rx0000108 | AvKare | 04/29/2024 | URSODIOL 500MG TABLET 100ct | ||||
Rx0000429 | Axsome Therapeutics, Inc. | 04/29/2024 | Sunosi Tablets 150mg 30 | 05/09/2022 | Jazz Pharmaceuticals, Inc. | 53000000 | Axsome aquired Sunosi with a total upfront payment of $53 million, a high single-digit royalty on Axsome's U.S. net sales of Sunosi in the current indication, and a mid single-digit royalty on Axsome's U.S. net sales of Sunosi in future indications. |
Rx0000429 | Axsome Therapeutics, Inc. | 04/29/2024 | Sunosi Tablets 75mg 30 | 05/09/2022 | Jazz Pharmaceuticals, Inc. | 53000000 | Axsome aquired Sunosi with a total upfront payment of $53 million, a high single-digit royalty on Axsome's U.S. net sales of Sunosi in the current indication, and a mid single-digit royalty on Axsome's U.S. net sales of Sunosi in future indications. |
Rx0000430 | Azurity Pharmaceuticals | 04/17/2024 | QBRELIS® (lisinopril) Oral Solution, 1 mg / mL, 150 mL | ||||
Rx0000430 | Azurity Pharmaceuticals | 03/31/2024 | Xatmep 2.5/ml (methotrexate) Oral Solution 120ml | ||||
Rx0000430 | Azurity Pharmaceuticals | 03/31/2024 | Xatmep 2.5mg/ml (methotrexate) Oral Solution 60ml | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | ALREX® (loteprednol etabonate ophthalmic suspension 0.2%), 10mL | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | ALREX® (loteprednol etabonate ophthalmic suspension 0.2%), 5mL | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | BEPREVE Ophthalmic Solution USP, 1.5%, 10mL | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | BEPREVE Ophthalmic Solution USP, 1.5%, 5mL | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | BESIVANCE® (besifloxacin ophthalmic suspension 0.6%), 5mL | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | LOTEMAX® (loteprednol etabonate ophthalmic Gel 0.5%), 5g | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | LOTEMAX® (loteprednol etabonate ophthalmic Ointment 0.5%), 3.5g | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | LOTEMAX® (loteprednol etabonate ophthalmic suspension 0.5%), 10mL | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | LOTEMAX® (loteprednol etabonate ophthalmic suspension 0.5%), 15mL | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | LOTEMAX® (loteprednol etabonate ophthalmic suspension 0.5%), 5mL | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | LOTEMAX® SM (loteprednol etabonate ophthalmic gel) 0.38%, 5g | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | MIOCHOL®-E (acetylcholine chloride intraocular solution), 20mg/2 mL, Vial | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | PROLENSA (bromfenac ophthalmic solution) 0.07% 3mL | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | TIMOPTIC® in OCUDOSE® (TIMOLOL MALEATE OPHTHALMIC SOLUTION - New NDC), 0.50%, 0.3mL, 60ct | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | TIMOPTIC® in OCUDOSE® (TIMOLOL MALEATE OPHTHALMIC SOLUTION) 0.25%, 0.3mL, 60ct | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | VYZULTA (latanoprostene bunod ophthalmic solution) 0.024%, 2.5mL | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | VYZULTA (latanoprostene bunod ophthalmic solution) 0.024%, 5mL | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | XIIDRA® (lifitegrast ophthalmic solution) 5%, 60ct | 09/29/2023 | Novartis | 250000000 | Bausch and Lomb Americas Inc. acquired XIIDRA and the other ophthalmology assets from Novartis for up to $2.5 billion, including an upfront payment of $1.75 billion in cash with potential milestone obligations of up to $750 million based on sales thresholds and pipeline commercialization. The system would not allow us to enter the full $2.5b in the acquisition price field so a zero was removed for the system to accept the entry. |
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | ZIRGAN (Ganciclovir Ophthalmic Gel 0.15%), 5mL | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | ZYLET® (loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic Suspension), 10mL | ||||
Rx0000096 | Bausch + Lomb, Inc. | 04/28/2024 | ZYLET® (loteprednol etabonate 0.5% and tobramycin 0.3% ophthalmic Suspension), 5mL | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | APLENZIN® (bupropion hydrobromide), Extended-Release Tablets, 174mg 30ct | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | APLENZIN® (bupropion hydrobromide), Extended-Release Tablets, 348mg 30ct | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | APLENZIN® (bupropion hydrobromide), Extended-Release Tablets, 522mg 30ct | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | ARAZLO (tazarotene) Lotion, 0.045%, 45g | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | ATIVAN® Tablets 1mg 1,000s | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | ATIVAN® Tablets .5mg 100s | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | ATIVAN® Tablets 1mg 100s | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | ATIVAN® Tablets 2mg 100s | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | BRYHALI (halobetasol propionate) Lotion 0.01%, 100g | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | BRYHALI (halobetasol propionate) Lotion 0.01%, 60g | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | DEMSER® (metyrosine), 250mg Capsules, 100ct | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | Duobrii (halobetasol propionate and tazarotene) Lotion 0.01%/0.045%, 1 | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | JUBLIA® (efinaconazole) Topical Solution 10%, 4mL | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | JUBLIA® (efinaconazole) Topical Solution 10%, 8mL | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | MESTINON 60mg /SYRUP (pyridostigmine bromide) 473mL 1 Bottle | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | MESTINON 60mg TABLETS 100s (pyridostigmine bromide) | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | MESTINON TIMESPAN 180mg TABLETS (pyridostigmine bromide) 30 CT | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | MYSOLINE 250 mg TABLETS, 100s (primidone) | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | MYSOLINE 50 mg TABLETS, 100s (primidone) | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | SILIQ (brodalumab) Injection 210mg/1.5mL (1 box of 2 syringes) | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | VASOTEC® 2.5mg Tablets, 90s | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | VASOTEC® 10mg Tablets, 1,000s | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | VASOTEC® 10mg Tablets, 30s | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | VASOTEC® 10mg Tablets, 90s | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | VASOTEC® 2.5mg Tablets, 30s | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | VASOTEC® 20mg Tablets, 1,000s | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | VASOTEC® 20mg Tablets, 30s | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | VASOTEC® 20mg Tablets, 90s | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | VASOTEC® 5mg Tablets, 30s | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | VASOTEC® 5mg Tablets, 90s | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | WELLBUTRIN® XL 150mg Tablets, 30ct | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | WELLBUTRIN® XL 150mg Tablets, 90ct | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | WELLBUTRIN® XL 300mg Tablets, 30ct | ||||
Rx0000097 | Bausch Health US, LLC | 04/28/2024 | ZELAPAR (selegiline HCI) 1.25mg Orally Disintegrating Tablets, 60ct | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 0.45% SODIUM CHL INJ,1000ML, 14 USPVIAFLEX PLASTIC CONTAINER | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 0.9% NACL INJ USP 50 ML, 96 MINI-BAG TM VIAFLEX CONT. | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 0.9% NACL INJ USP, 100ML, 80 MINI-BAG PLUS CONT | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 0.9% NACL INJ. USP 100 ML, 96 MINI-BAG TM VIAFLEX CONT | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 0.9% SOD CHL 100ML, 96 MINI-BAG VIAFLEX CONT | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 0.9% SOD CHL IRRIG, USP, 3000ML ARTHROMATIC, 4 Plastic Cont. | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 0.9% SOD CHL IRRIG, USP, 3000ML ARTHROMATIC, 4 Plastic Cont. | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 0.9% SOD.CHL.IRRIG. USP 3000ML, 4 UROMATIC CONTAINER | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 0.9% SOD.CHL.IRRIG. USP 3000ML, 4 UROMATIC CONTAINER | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 10% DEXTROSE INJECTION USP 250ML MIGRATED, 36 Flex Cont. | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 20 MEQ POT CHL IN .9% SOD CHLINJ,USP 1000ML, 14 Flex Cont. | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 20MEQ POT CHL IN 5% DEX&0.9%SOD CHL INJ, USP 1000ML, 14 Flex Cont. | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 5% DEX AND 0.45% SOD CHL INJ,USP 1000ML, 14 Flex Cont. | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 5% DEX AND 0.9% SOD CHL ING,USP 1000ML, 14 Flex Cont. | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 5% DEX INJ, USP, 100 ML , 80 MINI-BAG PLUS CONTAINER | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | 5% DEX INJ, USP, 50ML, 80 MINI-BAG PLUS CONTAINER | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | DEXTROSE 5% INJECTION USP 1000ML MIGRATED, 14 flex cont. | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | DEXTROSE 5% INJECTION USP 250ML MIGRATED, 36 Flex Cont. | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | LACTATED RINGERS & 5% DEXTROSEINJ, USP 1000ML, 14 Flex Cont. | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | LACTATED RINGERS IRRIG, 3000 ML ARTHROMATIC, 4 Plastic Cont. | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | NACL 0.9% INJ USP 50ML, 96 MINI-BAG TM VIAFLEX MIGRATED | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | PLASMA-LYTE A INJECTION PH 7.4MULTIPLE 1000ML 14 Flex Cont. | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | SOD CHLOR 0.9% INJ USP 100ML, 96 MINI- BAG TM VIAFLEX MIGRATED | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | SOD CHLOR 0.9% INJ USP 50ML, 80 MINI-BAG PLUS CONT MIGRATED | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | SOD CHLOR 0.9% INJ USP250ML, 36 VIAFLEXPLASTIC MIGRATED | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | STERILE WATER FOR INJ.USP 1000ML, 14 Flex Cont | ||||
Rx0000049 | Baxter Healthcare Corporation | 10/23/2024 | STERILE WATER FOR INJ.USP 1000ML, 14 Flex Cont | ||||
Rx0000024 | Bayer | 03/31/2024 | ADEMPAS 0.5 MG TABLET 9 count | ||||
Rx0000024 | Bayer | 03/31/2024 | ADEMPAS 0.5 MG TABLET 90 count | ||||
Rx0000024 | Bayer | 03/31/2024 | ADEMPAS 1 MG TABLET 9 count | ||||
Rx0000024 | Bayer | 03/31/2024 | ADEMPAS 1 MG TABLET 90 count | ||||
Rx0000024 | Bayer | 03/31/2024 | ADEMPAS 1.5 MG TABLET 9 count | ||||
Rx0000024 | Bayer | 03/31/2024 | ADEMPAS 1.5 MG TABLET 90 count | ||||
Rx0000024 | Bayer | 03/31/2024 | ADEMPAS 2 MG TABLET 9 count | ||||
Rx0000024 | Bayer | 03/31/2024 | ADEMPAS 2 MG TABLET 90 count | ||||
Rx0000024 | Bayer | 03/31/2024 | ADEMPAS 2.5 MG TABLET 9 count | ||||
Rx0000024 | Bayer | 03/31/2024 | ADEMPAS 2.5 MG TABLET 90 count | ||||
Rx0000024 | Bayer | 03/31/2024 | BETASERON-01 | ||||
Rx0000024 | Bayer | 03/31/2024 | BETASERON-35 | ||||
Rx0000024 | Bayer | 03/31/2024 | Nexavar 200mg 120 Tablets | ||||
Rx0000024 | Bayer | 03/31/2024 | Stivarga 40 mg tab 21 count bottle | ||||
Rx0000024 | Bayer | 03/31/2024 | Stivarga 40 mg tab 28 count bottle | ||||
Rx0000024 | Bayer | 03/31/2024 | Stivarga 40 mg tab 3x28 count bottle | ||||
Rx0000024 | Bayer | 03/31/2024 | Stivarga 40 mg tab 4x21 count bottle | ||||
Rx0000024 | Bayer | 03/31/2024 | VITRAKVI 100MG CAPS BT 1x60 | ||||
Rx0000024 | Bayer | 03/31/2024 | Vitrakvi 20 mg/mL oral solution | ||||
Rx0000024 | Bayer | 03/31/2024 | VITRAKVI 25MG CAPS BT 1x60 | ||||
Rx0000103 | Biocodex USA | 03/31/2024 | Diacomit 250mg Capsule 60ct | ||||
Rx0000103 | Biocodex USA | 08/21/2024 | Diacomit 250mg Capsule 60ct | ||||
Rx0000103 | Biocodex USA | 03/31/2024 | Diacomit 250mg Packet 60ct | ||||
Rx0000103 | Biocodex USA | 08/21/2024 | Diacomit 250mg Packet 60ct | ||||
Rx0000103 | Biocodex USA | 03/31/2024 | Diacomit 500mg Capsule 60ct | ||||
Rx0000103 | Biocodex USA | 08/21/2024 | Diacomit 500mg Capsule 60ct | ||||
Rx0000103 | Biocodex USA | 03/31/2024 | Diacomit 500mg Packet 60ct | ||||
Rx0000103 | Biocodex USA | 08/21/2024 | Diacomit 500mg Packet 60ct | ||||
Rx0000261 | BioMarin Pharmaceutical Inc | 07/15/2024 | BRINEURA 150 mg/5 mL INJ, Kit (Two 5 mL vials (30mg/ml) (IEV)-one 5ml vial) | ||||
Rx0000261 | BioMarin Pharmaceutical Inc | 07/15/2024 | NAGLAZYME 1MG/ML INJ, (5 mL vial) | ||||
Rx0000261 | BioMarin Pharmaceutical Inc | 07/15/2024 | PALYNZIQ 10MG/0.5ML INJ,SYR,0.5MLsingle-dose prefilled syringe | ||||
Rx0000261 | BioMarin Pharmaceutical Inc | 07/15/2024 | PALYNZIQ 2.5MG/0.5ML INJ,SYR,0.5ML single-dose prefilled syringe | ||||
Rx0000261 | BioMarin Pharmaceutical Inc | 07/15/2024 | PALYNZIQ 20MG/ML INJ,SYR,1ML single-dose prefilled syringe | ||||
Rx0000261 | BioMarin Pharmaceutical Inc | 07/15/2024 | PALYNZIQ 20MG/ML INJ,SYR,1ML Ten 1 mL single- dose prefilled syringes | ||||
Rx0000261 | BioMarin Pharmaceutical Inc | 07/15/2024 | VIMIZIM 1MG/ML INJ,SOLN,5ML vial | ||||
Rx0000038 | Boehringer Ingelheim | 04/26/2024 | OFEV 100MG CAPSULE 60 | ||||
Rx0000038 | Boehringer Ingelheim | 04/26/2024 | OFEV 150MG CAPSULE 60 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ABECMA® 250 mL infusion bag and metal cassette | 11/20/2019 | Celgene | 74000000000 | Bristol-Myers Squibb Company (BMS) acquired Celgene Corporation (Celgene) in November 2019 for $74,000,000,000. Note that the product was acquired prior to commercialization, as a result of system limitations the WAC at Acquisition & WAC Amount Year Prior fields have been populated with the WAC at launch as a workaround. |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ABECMA® 50 mL infusion bag and metal cassette | 11/20/2019 | Celgene | 74000000000 | Bristol-Myers Squibb Company (BMS) acquired Celgene Corporation (Celgene) in November 2019 for $74,000,000,000. Note that the product was acquired prior to commercialization, as a result of system limitations the WAC at Acquisition & WAC Amount Year Prior fields have been populated with the WAC at launch as a workaround. |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ABECMA® 500 mL infusion bag and metal cassette | 11/20/2019 | Celgene | 74000000000 | Bristol-Myers Squibb Company (BMS) acquired Celgene Corporation (Celgene) in November 2019 for $74,000,000,000. Note that the product was acquired prior to commercialization, as a result of system limitations the WAC at Acquisition & WAC Amount Year Prior fields have been populated with the WAC at launch as a workaround. |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | BREYANZI® Carton up to 4 vials of cryopreserved CAR-positive T cells | 11/20/2019 | Celgene | 74000000000 | Bristol-Myers Squibb Company (BMS) acquired Celgene Corporation (Celgene) in November 2019 for $74,000,000,000. Note that the product was acquired prior to commercialization, as a result of system limitations the WAC at Acquisition & WAC Amount Year Prior fields have been populated with the WAC at launch as a workaround. |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ELIQUIS® 2.5 mg tablet 60 count bottle | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ELIQUIS® 2.5 mg tablet pack of 100 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ELIQUIS® 5 mg tablet 60 count bottle | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ELIQUIS® 5 mg tablet 74 count bottle | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ELIQUIS® 5 mg tablet pack of 100 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ELIQUIS® 5 mg tablet pack of 74 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | IDHIFA® 100mg, 30 Tablets/Bottle | 11/20/2019 | Celgene | 74000000000 | Bristol-Myers Squibb Company (BMS) acquired Celgene Corporation (Celgene) in November 2019 for $ 74,000,000,000. |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | IDHIFA® 50mg, 30 Tablets/Bottle | 11/20/2019 | Celgene | 74000000000 | Bristol-Myers Squibb Company (BMS) acquired Celgene Corporation (Celgene) in November 2019 for $ 74,000,000,000. |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | INREBIC® 100mg, 120 Capsules/Bottle | 11/20/2019 | Celgene | 74000000000 | Bristol-Myers Squibb Company (BMS) acquired Celgene Corporation (Celgene) in November 2019 for $ 74,000,000,000. |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ONUREG® 200 mg tablet pack of 7 | 11/20/2019 | Celgene | 74000000000 | Bristol-Myers Squibb Company (BMS) acquired Celgene Corporation (Celgene) in November 2019 for $74,000,000,000. Note that the product was acquired prior to commercialization, as a result of system limitations the WAC at Acquisition & WAC Amount Year Prior fields have been populated with the WAC at launch as a workaround. |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ONUREG® 300 mg tablet pack of 7 | 11/20/2019 | Celgene | 74000000000 | Bristol-Myers Squibb Company (BMS) acquired Celgene Corporation (Celgene) in November 2019 for $74,000,000,000. Note that the product was acquired prior to commercialization, as a result of system limitations the WAC at Acquisition & WAC Amount Year Prior fields have been populated with the WAC at launch as a workaround. |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ORENCIA® 125 mg Solution, 1ml Single Dose Prefilled Auto-injector, pack of 4 Auto-Injectors | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ORENCIA® 125 mg Solution, 1ml Single Dose Prefilled Syringe, pack of 4 Syringes | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ORENCIA® 250 mg lyophilized powder | ||||
Rx0000078 | Bristol Myers Squibb | 10/15/2024 | ORENCIA® 250 mg lyophilized powder | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ORENCIA® 50 mg/0.4ml Solution, 0.4ml Single Dose Prefilled Syringe, pack of 4 Syringes | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ORENCIA® 87.5 mg/0.7ml Solution, 0.7ml Single Dose Prefilled Syringe, pack of 4 Syringes | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | POMALYST® 1 mg capsule pack of 100 | 11/20/2019 | Celgene | 74000000000 | Bristol-Myers Squibb Company (BMS) acquired Celgene Corporation (Celgene) in November 2019 for $ 74,000,000,000. |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | POMALYST® 1 mg capsule pack of 21 | 11/20/2019 | Celgene | 74000000000 | Bristol-Myers Squibb Company (BMS) acquired Celgene Corporation (Celgene) in November 2019 for $ 74,000,000,000. |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | POMALYST® 2 mg capsule pack of 100 | 11/20/2019 | Celgene | 74000000000 | Bristol-Myers Squibb Company (BMS) acquired Celgene Corporation (Celgene) in November 2019 for $ 74,000,000,000. |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | POMALYST® 2 mg capsule pack of 21 | 11/20/2019 | Celgene | 74000000000 | Bristol-Myers Squibb Company (BMS) acquired Celgene Corporation (Celgene) in November 2019 for $ 74,000,000,000. |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | POMALYST® 3 mg capsule pack of 100 | 11/20/2019 | Celgene | 74000000000 | Bristol-Myers Squibb Company (BMS) acquired Celgene Corporation (Celgene) in November 2019 for $ 74,000,000,000. |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | POMALYST® 3 mg capsule pack of 21 | 11/20/2019 | Celgene | 74000000000 | Bristol-Myers Squibb Company (BMS) acquired Celgene Corporation (Celgene) in November 2019 for $ 74,000,000,000. |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | POMALYST® 4 mg capsule pack of 100 | 11/20/2019 | Celgene | 74000000000 | Bristol-Myers Squibb Company (BMS) acquired Celgene Corporation (Celgene) in November 2019 for $ 74,000,000,000. |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | POMALYST® 4 mg capsule pack of 21 | 11/20/2019 | Celgene | 74000000000 | Bristol-Myers Squibb Company (BMS) acquired Celgene Corporation (Celgene) in November 2019 for $ 74,000,000,000. |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | SPRYCEL® 100 mg tablet, bottle of 30 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | SPRYCEL® 140 mg tablet, bottle of 30 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | SPRYCEL® 20 mg tablet, bottle of 60 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | SPRYCEL® 50 mg tablet, bottle of 60 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | SPRYCEL® 70 mg tablet, bottle of 60 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | SPRYCEL® 80 mg tablet, bottle of 30 | ||||
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ZEPOSIA® 0.23, 0.46MG TITR STR PCK 7CT US (Wallet) | 11/20/2019 | Celgene | 74000000000 | Bristol-Myers Squibb Company (BMS) acquired Celgene Corporation (Celgene) in November 2019 for $74,000,000,000. Note that the product was acquired prior to commercialization, as a result of system limitations the WAC at Acquisition & WAC Amount Year Prior fields have been populated with the WAC at launch as a workaround. |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ZEPOSIA® 0.23,0.46,0.92MG 28CT KIT US | 11/20/2019 | Celgene | 74000000000 | Bristol-Myers Squibb Company (BMS) acquired Celgene Corporation (Celgene) in November 2019 for $74,000,000,000. Note that the product was acquired prior to commercialization, as a result of system limitations the WAC at Acquisition & WAC Amount Year Prior fields have been populated with the WAC at launch as a workaround. |
Rx0000078 | Bristol Myers Squibb | 04/29/2024 | ZEPOSIA® 0.92MG CAP 30CT BTL US | 11/20/2019 | Celgene | 74000000000 | Bristol-Myers Squibb Company (BMS) acquired Celgene Corporation (Celgene) in November 2019 for $74,000,000,000. Note that the product was acquired prior to commercialization, as a result of system limitations the WAC at Acquisition & WAC Amount Year Prior fields have been populated with the WAC at launch as a workaround. |
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Firdapse 10mg Tablet 240/Bottle | ||||
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Firdapse Blister shelf pack of 120 - 10mg tablets | ||||
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 0.05MG/ML Oral Suspension | 01/24/2023 | Eisai, Inc. | ||
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 0.05MG/ML Oral Suspension 340 | ||||
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 10mg Tablet | 01/24/2023 | Eisai, Inc. | ||
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 10mg Tablet 30 | ||||
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 12mg Tablet | 01/24/2023 | Eisai, Inc. | ||
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 12mg Tablet 30 | ||||
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 2mg Tablet | 01/24/2023 | Eisai, Inc. | ||
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 2mg Tablet 30 | ||||
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 4mg Tablet | 01/24/2023 | Eisai, Inc. | ||
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 4mg Tablet 30 | ||||
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 6mg Tablet | 01/24/2023 | Eisai, Inc. | ||
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 6mg Tablet 30 | ||||
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 8mg Tablet | 01/24/2023 | Eisai, Inc. | ||
Rx0000498 | Catalyst Pharmaceuticals Inc | 04/09/2024 | Fycompa 8mg Tablet 30 | ||||
Rx0000139 | Chiesi USA | 04/11/2024 | Cleviprex injectable emulsion 25mg/50mL 10 vials in 1 box - Emulsion | 06/21/2016 | The Medicines Company | ||
Rx0000139 | Chiesi USA | 04/11/2024 | Cleviprex injectable emulsion 50mg/100mL 10 vials in 1 box - Emulsion | 06/21/2016 | The Medicines Company | ||
Rx0000139 | Chiesi USA | 04/09/2024 | Curosurf® 1.5ml 80mg/mL 1 1.5mL vial - Suspension | ||||
Rx0000139 | Chiesi USA | 04/09/2024 | Curosurf® 3.0ml 80mg/mL 1 3.0mL vial - Suspension | ||||
Rx0000139 | Chiesi USA | 04/08/2024 | Ferriprox ORAL SOLUTION 100mg/1mL 1 bottle of 500 mL - Solution | 01/06/2020 | ApoPharma Inc. | ||
Rx0000139 | Chiesi USA | 04/08/2024 | Ferriprox TD 1000mg FILM COATED TABLETS 1000mg 1 carton of 5 blister packs - Tablet | ||||
Rx0000139 | Chiesi USA | 04/12/2024 | Juxtapid Oral Capsule 10 MG 1 package of 28 capsules - Capsule | 04/12/2023 | Amryt Pharma Plc | ||
Rx0000139 | Chiesi USA | 04/12/2024 | Juxtapid Oral Capsule 20 MG 1 package of 28 capsules - Capsule | 04/12/2023 | Amryt Pharma Plc | ||
Rx0000139 | Chiesi USA | 04/12/2024 | Juxtapid Oral Capsule 30 MG 1 package of 28 capsules - Capsule | 04/12/2023 | Amryt Pharma Plc | ||
Rx0000139 | Chiesi USA | 04/12/2024 | Juxtapid Oral Capsule 5 MG 1 package of 28 capsules - Capsule | 04/12/2023 | Amryt Pharma Plc | ||
Rx0000139 | Chiesi USA | 04/08/2024 | Kengreal for injection 50mg/10ML 50mg 1 box of 28 ampules - Solution | ||||
Rx0000139 | Chiesi USA | 04/11/2024 | Myalept Subcutaneous Soltution Reconsituted 11.3 MG 1 vial - Injectable | 04/12/2023 | Amryt Pharma Plc | ||
Rx0000139 | Chiesi USA | 04/10/2024 | Mycapssa 20mg 1 package of 28 capsules - Capsule | 04/12/2023 | Amryt Pharma Plc | ||
Rx0000139 | Chiesi USA | 04/08/2024 | Revcovi® (elapegademase-IvIr 1.6mg/ml) Injection 1 vial 2.4mg/1.5mL - Solution | 11/24/2020 | Leadiant Biosciences | ||
Rx0000080 | Cipla USA, Inc. | 07/15/2024 | Griseofulvin Oral Suspension USP (microsize) 125mg/5ml, 120ml | ||||
Rx0000320 | CMP Pharma | 03/31/2024 | Sodium Polystyrene Sulfonate, suspension, 15g/60ml, 10 BOTTLE in 1 CARTON 60 mL in 1 BOTTLE, | ||||
Rx0000320 | CMP Pharma | 03/31/2024 | Sodium Polystyrene Sulfonate, suspension, 15g/60mL, 120 mL in 1 BOTTLE | ||||
Rx0000320 | CMP Pharma | 03/31/2024 | Sodium Polystyrene Sulfonate, suspension, 15g/60ml, 473 mL in 1 BOTTLE | ||||
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Belbuca 150mg, 1 box of 60 films | 03/22/2022 | BioDelivery Sciences International, Inc | 669431000 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Belbuca 300mg 1 box of 60 films | 03/22/2022 | BioDelivery Sciences International, Inc | 669431000 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Belbuca 450mg, 1 box of 60 films | 03/22/2022 | BioDelivery Sciences International, Inc | 669431000 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Belbuca 600mg, 1 box of 60 films | 03/22/2022 | BioDelivery Sciences International, Inc | 669431000 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Belbuca 750mg, 1 box of 60 films | 03/22/2022 | BioDelivery Sciences International, Inc | 669431000 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Belbuca 900mg, 1 box of 60 films | 03/22/2022 | BioDelivery Sciences International, Inc | 669431000 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Belbuca, 75mg, 1 box of 60 films | 03/22/2022 | BioDelivery Sciences International, Inc | 669431000 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Nucynta 100mg, tablet, 100 pack | 02/14/2020 | Assertio Therapeutics, Inc. | 375000000 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Nucynta 50mg, tablet, 100 pack | 02/14/2020 | Assertio Therapeutics, Inc. | 375000000 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Nucynta 75mg, tablet, 100 pack | 02/14/2020 | Assertio Therapeutics, Inc. | 375000000 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Nucynta ER 100mg, tablet, 60 pack | 02/14/2020 | Assertio Therapeutics, Inc. | 375000000 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Nucynta ER 150 mg, tablet, 60 pack | 02/14/2020 | Assertio Therapeutics, Inc. | 375000000 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Nucynta ER 200 mg, tablet, 60 pack | 02/14/2020 | Assertio Therapeutics, Inc. | 375000000 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Nucynta ER 250 mg, tablet, 60 pack | 02/14/2020 | Assertio Therapeutics, Inc. | 375000000 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Nucynta ER 50mg, tablet, 60 pack | 02/14/2020 | Assertio Therapeutics, Inc. | 375000000 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Symproic 0.2 mg, 1 bottle of 30 tablets | 03/22/2022 | BioDelivery Sciences International, Inc | 669431000 | |
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Xtampza ER 13.5mg, capsule, 100 pack | ||||
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Xtampza ER 18mg, capsule, 100 pack | ||||
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Xtampza ER 27mg, capsule, 100 pack | ||||
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Xtampza ER 36mg, capsule, 100 pack | ||||
Rx0000200 | Collegium Pharmaceuticals | 04/19/2024 | Xtampza ER 9mg, capsule, 100 pack | ||||
Rx0000154 | Corcept Therapeutics Incorporated | 04/29/2024 | Korlym (mifepristone) 300mg Tablet (Bottle of 28) | ||||
Rx0000154 | Corcept Therapeutics Incorporated | 04/29/2024 | Korlym (mifepristone) 300mg Tablet (Bottle of 280) | ||||
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Azor Tablets 10 mg/20 mg | 01/01/2022 | Daiichi Sankyo | ||
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Azor Tablets 10 mg/40 mg | 01/01/2022 | Daiichi Sankyo | ||
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Azor Tablets 5 mg/20 mg | 01/01/2022 | Daiichi Sankyo | ||
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Azor Tablets 5 mg/40 mg | 01/01/2022 | Daiichi Sankyo | ||
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Benicar HCT Tablets 20 mg/12.5 mg | 01/01/2022 | Daiichi Sankyo | ||
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Benicar HCT Tablets 40 mg/12.5 mg | 01/01/2022 | Daiichi Sankyo | ||
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Benicar HCT Tablets 40 mg/25 mg | 01/01/2022 | Daiichi Sankyo | ||
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Benicar Tablets 20 mg | 01/01/2022 | Daiichi Sankyo | ||
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Benicar Tablets 40 mg | 01/01/2022 | Daiichi Sankyo | ||
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Benicar Tablets 5 mg | 01/01/2022 | Daiichi Sankyo | ||
Rx0000184 | Cosette Pharmaceuticals, Inc. | 04/11/2024 | Clomid Tablets 50 mg 30-ct box | 09/01/2022 | Par Pharmaceuticals | ||
Rx0000184 | Cosette Pharmaceuticals, Inc. | 04/11/2024 | Clomid Tablets 50 ng 10-ct box | 09/01/2022 | Par Pharmaceuticals | ||
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Effient Tablets 10 mg | 01/01/2022 | Daiichi Sankyo | ||
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Effient Tablets 5 mg | 01/01/2022 | Daiichi Sankyo | ||
Rx0000184 | Cosette Pharmaceuticals, Inc. | 04/11/2024 | Migergot Suppositories 2-100 mg 12-ct box | ||||
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Tribenzor Tablets 20 mg/5 mg/12.5 mg | 01/01/2022 | Daiichi Sankyo | ||
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Tribenzor Tablets 40 mg/10 mg/12.5 mg | 01/01/2022 | Daiichi Sankyo | ||
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Tribenzor Tablets 40 mg/10 mg/25 mg | 01/01/2022 | Daiichi Sankyo | ||
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Tribenzor Tablets 40 mg/5 mg/12.5 mg | 01/01/2022 | Daiichi Sankyo | ||
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Tribenzor Tablets 40 mg/5 mg/25 mg | 01/01/2022 | Daiichi Sankyo | ||
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Welchol for Oral Suspension 3.75 g | 01/01/2022 | Daiichi Sankyo | ||
Rx0000184 | Cosette Pharmaceuticals, Inc. | 10/24/2024 | Welchol Tablets 625 mg | 01/01/2022 | Daiichi Sankyo | ||
Rx0000425 | CSL Behring LLC | 04/10/2024 | Berinert 500 units (500 IU / Solution / Pkg Size 1) | ||||
Rx0000425 | CSL Behring LLC | 09/20/2024 | Berinert 500 units (500 IU / Solution / Pkg Size 1) | ||||
Rx0000425 | CSL Behring LLC | 09/20/2024 | Haegarda 2000iu / 2000iu Solution / UOM EA = 1 vial | ||||
Rx0000425 | CSL Behring LLC | 09/20/2024 | Haegarda 3000iu / 3000iu Solution / UOM EA = 1 vial | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 10 ml (2g) - inner / 2gm Solution / UOM EA = 1 vial | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 10 ml (2g) PFS - inner / 2gm Solution / UOM EA = 1 vial | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 10 ml (2g) PFS / 2gm Solution / UOM EA = 1 vial | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 10 ml (2g) / 2gm Solution / UOM EA = 1 vial | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 20 ml (4g) - inner / 4gm Solution / UOM EA = 1 vial | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 20 ml (4g) PFS - inner / 4gm Solution / UOM EA = 1 vial | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 20 ml (4g) PFS / 4gm Solution / UOM EA = 1 vial | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 20 ml (4g) / 4gm Solution / UOM EA = 1 vial | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 5 ml (1g) - inner / 1gm Solution / UOM EA = 1 vial | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 5 ml (1g) / 1gm Solution / UOM EA = 1 vial | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 5 ml (1g) PFS - inner / 1gm Solution / UOM EA = 1 vial | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 5 ml (1g) PFS / 1gm Solution / UOM EA = 1 vial | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 50 ml (10g) - inner / 10gm Solution / UOM EA = 1 vial | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 50 ml (10g) / 10gm Solution / UOM EA = 1 vial | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 50 ml (10g) PFS - inner / 10gm Solution / UOM EA = 1 vial | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Hizentra 50 ml (10g) PFS / 10gm Solution / UOM EA = 1 vial | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Privigen 100ml (10g) - Inner / 10gm Solution / UOM EA = 1 vial | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Privigen 100ml (10g) / 10gm Solution / UOM EA = 1 vial | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Privigen 200ml (20g) - Inner / 20gm Solution / UOM EA = 1 vial | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Privigen 200ml (20g) / 20gm Solution / UOM EA = 1 vial | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Privigen 400ml (40g) - Inner / 40gm Solution / UOM EA = 1 vial | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Privigen 400ml (40g) / 40gm Solution / UOM EA = 1 vial | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Privigen 50ml (5g) - Inner / 5gm Solution / UOM EA = 1 vial | ||||
Rx0000425 | CSL Behring LLC | 09/13/2024 | Privigen 50ml (5g) / 5gm Solution / UOM EA = 1 vial | ||||
Rx0000230 | Cumberland Pharmaceuticals | 05/01/2024 | CALDOLOR VIALS 25 5mL VIA. | ||||
Rx0000230 | Cumberland Pharmaceuticals | 07/09/2024 | KRISTALOSE 10GM SOLD BY CASE (30 PACKETS) | ||||
Rx0000230 | Cumberland Pharmaceuticals | 07/09/2024 | KRISTALOSE 20GM SOLD BY CASE (30 PACKETS) | ||||
Rx0000230 | Cumberland Pharmaceuticals | 07/09/2024 | VIBATIV 750MG CASE OF 12 SINGLE DOSE VIALS | ||||
Rx0000216 | Deciphera Pharmaceuticals, LLC | 04/29/2024 | Qinlock Oral Tablet 50 MG, 90 Each, Bottle | ||||
Rx0000216 | Deciphera Pharmaceuticals, LLC | 10/03/2024 | Qinlock Oral Tablet 50 MG, 90 Each, Bottle | ||||
Rx0000492 | Dynavax Technologies Corporation | 03/31/2024 | HEPLISAV-B [Hepatitis B Vaccine (Recombinant)] Adjuvanted 20 MCG / 0.5 ML PFS Injection, Solution 5 SYRINGE in 1 CARTON (43528-003-05) / .5 mL in 1 SYRINGE (43528-003-01) | ||||
Rx0000282 | Edenbridge Pharmaceuticals, LLC | 07/03/2024 | METHENAMINE MANDELATE - 0.5g Oral Tablet, 100ct Bottle [Qty: 1] | ||||
Rx0000282 | Edenbridge Pharmaceuticals, LLC | 07/03/2024 | METHENAMINE MANDELATE -1g Oral Tablet, 100ct Bottle [Qty: 1] | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | Lenvatinib Mesylate 10 & 4 MG Capsule Therapy Pack 10 EA UU | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | Lenvatinib Mesylate 10 MG & 2 x 4 MG Capsule Therapy Pack 15 EA UU | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | Lenvatinib Mesylate 10 MG Capsule Therapy Pack 5 EA UU | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | Lenvatinib Mesylate 2 x 10 MG & 4 MG Capsule Therapy Pack 15 EA UU | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | Lenvatinib Mesylate 2 x 10 MG Capsule Therapy Pack 10 EA UU | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | Lenvatinib Mesylate 2 x 4 MG Capsule Therapy Pack 10 EA UU | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | Lenvatinib Mesylate 3 x 4 MG Capsule Therapy Pack 15 EA UU | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | Lenvatinib Mesylate 3 x 4 MG Capsule Therapy Pack 90 EA UU | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | Lenvatinib Mesylate 4 MG Capsule Therapy Pack 30 EA UU | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | Lenvatinib Mesylate 4 MG Capsule Therapy Pack 5 EA UU | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | LENVIMA (lenvatinib mesylate) 8 mg/day (4 mg x 2) 60 count | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | LENVIMA (lenvatinib mesylate)10 mg/day (10 mg x 1) 30 count | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | LENVIMA (lenvatinib mesylate)14 mg/day (10 mg x 1 and 4 mg x 1) 60 count | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | LENVIMA (lenvatinib) 18 mg/day (10 mg x 1 and 4 mg x 2) 30 day supply | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | LENVIMA (lenvatinib) 20 mg/day (10 mg x 2) 30 day supply | ||||
Rx0000076 | Eisai Inc. | 04/30/2024 | LENVIMA (lenvatinib) 24 mg/day (10 mg x 2 and 4 mg x 1) 30 day supply | ||||
Rx0000114 | Eli Lilly and Company | 03/31/2024 | Verzenio Package Size: 14 Strength: 100 mg Dosage Form: TABLET | ||||
Rx0000114 | Eli Lilly and Company | 03/31/2024 | Verzenio Package Size: 14 Strength: 150 mg Dosage Form: TABLET | ||||
Rx0000114 | Eli Lilly and Company | 03/31/2024 | Verzenio Package Size: 14 Strength: 200 mg Dosage Form: TABLET | ||||
Rx0000114 | Eli Lilly and Company | 03/31/2024 | Verzenio Package Size: 14 Strength: 50 mg Dosage Form: TABLET | ||||
Rx0000079 | EMD Serono, Inc. | 04/30/2024 | Cetrotide Subcutaneous Kit 0.25 MG, 1 Each, Box | ||||
Rx0000079 | EMD Serono, Inc. | 07/26/2024 | Mavenclad (10 Tabs) Oral Tablet Therapy Pack 10 MG, 10 Each, Unit-of-Use, Box | ||||
Rx0000079 | EMD Serono, Inc. | 07/26/2024 | Mavenclad (4 Tabs) Oral Tablet Therapy Pack 10 MG, 4 Each, Unit-of-Use, Box | ||||
Rx0000079 | EMD Serono, Inc. | 07/26/2024 | Mavenclad (5 Tabs) Oral Tablet Therapy Pack 10 MG, 5 Each, Unit-of-Use, Box | ||||
Rx0000079 | EMD Serono, Inc. | 07/26/2024 | Mavenclad (6 Tabs) Oral Tablet Therapy Pack 10 MG, 6 Each, Unit-of-Use, Box | ||||
Rx0000079 | EMD Serono, Inc. | 07/26/2024 | Mavenclad (7 Tabs) Oral Tablet Therapy Pack 10 MG, 7 Each, Unit-of-Use, Box | ||||
Rx0000079 | EMD Serono, Inc. | 07/26/2024 | Mavenclad (8 Tabs) Oral Tablet Therapy Pack 10 MG, 8 Each, Unit-of-Use, Box | ||||
Rx0000079 | EMD Serono, Inc. | 07/26/2024 | Mavenclad (9 Tabs) Oral Tablet Therapy Pack 10 MG, 9 Each, Unit-of-Use, Box | ||||
Rx0000079 | EMD Serono, Inc. | 04/30/2024 | Ovidrel Subcutaneous Injectable 250 MCG/0.5ML, .5 ML, Unit-Dose, Syringe | ||||
Rx0000079 | EMD Serono, Inc. | 04/30/2024 | Rebif Rebidose Subcutaneous Solution Auto-injector 22 MCG/0.5ML, .5 ML, Unit-Dose, Syringe Qty 12 | ||||
Rx0000079 | EMD Serono, Inc. | 04/30/2024 | Rebif Rebidose Subcutaneous Solution Auto-injector 44 MCG/0.5ML, .5 ML, Unit-Dose, Syringe Qty 12 | ||||
Rx0000079 | EMD Serono, Inc. | 04/30/2024 | Rebif Rebidose Titration Pack Subcutaneous Solution Auto-injector 6X8.8 & 6X22 MCG, 4.2 ML, Unit-of-Use, Box | ||||
Rx0000079 | EMD Serono, Inc. | 04/30/2024 | Rebif Subcutaneous Solution Prefilled Syringe 22 MCG/0.5ML, .5 ML, Unit-Dose, Syringe Qty 12 | ||||
Rx0000079 | EMD Serono, Inc. | 04/30/2024 | Rebif Subcutaneous Solution Prefilled Syringe 44 MCG/0.5ML, .5 ML, Unit-Dose, Syringe Qty 12 | ||||
Rx0000079 | EMD Serono, Inc. | 04/30/2024 | Rebif Titration Pack Subcutaneous Solution Prefilled Syringe 6X8.8 & 6X22 MCG, 4.2 ML, Unit-of-Use, Box | ||||
Rx0000079 | EMD Serono, Inc. | 04/30/2024 | Serostim Subcutaneous Solution Reconstituted 4 MG, 1 Each, Unit-Dose, Vial Qty 7 | ||||
Rx0000079 | EMD Serono, Inc. | 04/30/2024 | Serostim Subcutaneous Solution Reconstituted 5 MG, 1 Each, Unit-Dose, Vial Qty 7 | ||||
Rx0000079 | EMD Serono, Inc. | 04/30/2024 | Serostim Subcutaneous Solution Reconstituted 6 MG, 1 Each, Unit-Dose, Vial Qty 7 | ||||
Rx0000079 | EMD Serono, Inc. | 04/30/2024 | Tepmetko Oral Tablet 225 MG, 30 Each, Box | ||||
Rx0000079 | EMD Serono, Inc. | 04/30/2024 | Tepmetko Oral Tablet 225 MG, 60 Each, Box | ||||
Rx0000557 | Emmaus Medical, Inc. | 03/31/2024 | ENDARI [L-glutamine oral powder], 5g/1, Powder for solution, 1 powder for solution in 1 packet | ||||
Rx0000557 | Emmaus Medical, Inc. | 03/31/2024 | ENDARI [L-glutamine oral powder], 5g/1, Powder for solution, 60 packet in 1 carton | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 07/31/2024 | Aveed, 750 mg/3mL (250mg/1mL) solution, single use vial | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | Edex®, Alprostadil For Inj Kit 10 MCG, 2 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | Edex®, Alprostadil For Inj Kit 10 MCG, 6 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | Edex®, Alprostadil For Inj Kit 20 MCG, 2 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | Edex®, Alprostadil For Inj Kit 20 MCG, 6 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | Edex®, Alprostadil For Inj Kit 40 MCG, 2 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | Edex®, Alprostadil For Inj Kit 40 MCG, 6 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | FROVA®, Frovatriptan Succinate Tab 2.5 MG (Base Equivalent), 9 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | PERCOCET®, Oxycodone w/ Acetaminophen Tab 10-325 MG, 100 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | PERCOCET®, Oxycodone w/ Acetaminophen Tab 2.5-325 MG, 100 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | PERCOCET®, Oxycodone w/ Acetaminophen Tab 5-325 MG, 100 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | PERCOCET®, Oxycodone w/ Acetaminophen Tab 5-325 MG, 500 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | PERCOCET®, Oxycodone w/ Acetaminophen Tab 7.5-325 MG, 100 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | THEO-24®, Theophylline Cap ER 24HR 100 MG, 100 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | THEO-24®, Theophylline Cap ER 24HR 200 MG, 100 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | THEO-24®, Theophylline Cap ER 24HR 300 MG, 100 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 04/30/2024 | THEO-24®, Theophylline Cap ER 24HR 400 MG, 100 | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 07/31/2024 | Valstar, 40 mg/1ml solution, 4x5mL | ||||
Rx0000091 | Endo Pharmaceuticals Inc. | 07/31/2024 | Xiaflex, 0.9mg powder for solution, single use vial | ||||
Rx0000584 | Endo USA, Inc. | 07/31/2024 | BREVITAL SODIUM METHOHEXITAL SODIUM INJECTABLE 500MG/VIAL | 04/23/2024 | Endo International plc | 0 | As of 4/23/2024, Endo, Inc. ("Endo"), a newly formed entity successfully completed the acquisition of substantially all of the assets of Endo International plc ("EIP"), as contemplated under EIP's plan of reorganization. As part Endos acquisition of EIPs assets, Endo acquired this product. However, Endo is unable to provide the purchase price for this product since Endo does not have a methodology to allocate the purchase price of this product from EIPs plan of reorganization. As a result, Endo has reported the Acquisition Price for this product as 0. |
Rx0000584 | Endo USA, Inc. | 07/31/2024 | TIGAN TRIMETHOBENZAMIDE HYDROCHLORIDE INJECTABLE 100MG/ML, 25vl | 04/23/2024 | Endo International plc | 0 | As of 4/23/2024, Endo, Inc. ("Endo"), a newly formed entity successfully completed the acquisition of substantially all of the assets of Endo International plc ("EIP"), as contemplated under EIP's plan of reorganization. As part Endos acquisition of EIPs assets, Endo acquired this product. However, Endo is unable to provide the purchase price for this product since Endo does not have a methodology to allocate the purchase price of this product from EIPs plan of reorganization. As a result, Endo has reported the Acquisition Price for this product as 0. |
Rx0000405 | Esperion | 03/31/2024 | Nexletol 30 Tab 180 mg/1 Tablet Film Coated | ||||
Rx0000405 | Esperion | 03/31/2024 | Nexlizet 30 Tab 180 mg/1, 10 mg/1 Tablet Film Coated | ||||
Rx0000270 | Eton Pharmaceuticals, Inc. | 04/25/2024 | Alkindi Sprinkle (hydrocortisone) Oral Granules 0.5 MG, 50 Capsules, Bottle | 03/27/2020 | Diurnal Group plc | 45000000 | |
Rx0000270 | Eton Pharmaceuticals, Inc. | 04/25/2024 | Alkindi Sprinkle (hydrocortisone) Oral Granules 1 MG, 50 Capsules, Bottle | 03/27/2020 | Diurnal Group plc | 45000000 | |
Rx0000270 | Eton Pharmaceuticals, Inc. | 04/25/2024 | Alkindi Sprinkle (hydrocortisone) Oral Granules 2 MG, 50 Capsules, Bottle | 03/27/2020 | Diurnal Group plc | 45000000 | |
Rx0000270 | Eton Pharmaceuticals, Inc. | 04/25/2024 | Alkindi Sprinkle (hydrocortisone) Oral Granules 5 MG, 50 Capsules, Bottle | 03/27/2020 | Diurnal Group plc | 45000000 | |
Rx0000455 | Evofem Biosciences, Inc. | 04/30/2024 | Phexxi Vaginal Gel 1.8-1-0.4%, 5 GM, Unit-of-Use, Box Qty 12 | ||||
Rx0000010 | Exelixis, Inc. | 04/30/2024 | CABOMETYX 20MG 30 TAB BTL EACH | ||||
Rx0000010 | Exelixis, Inc. | 04/30/2024 | CABOMETYX 40MG 30 TAB BTL EACH | ||||
Rx0000010 | Exelixis, Inc. | 04/30/2024 | CABOMETYX 60MG 30 TAB BTL EACH | ||||
Rx0000193 | Forte Bio-Pharma, LLC | 07/11/2024 | NALOCET TABLETS 1 PACK 100 TABS 2.5 MG/300 MG | ||||
Rx0000193 | Forte Bio-Pharma, LLC | 07/11/2024 | PROLATE TABLETS 1 PACK 100 TABS 10 MG/300 MG | ||||
Rx0000193 | Forte Bio-Pharma, LLC | 07/11/2024 | PROLATE TABLETS 1 PACK 100 TABS 5 MG/300 MG | ||||
Rx0000193 | Forte Bio-Pharma, LLC | 07/11/2024 | PROLATE TABLETS 1 PACK 100 TABS 7.5 MG/300 MG | ||||
Rx0000260 | Galderma Laboratories | 04/10/2024 | TRI-LUMA Cream 24x30g US | ||||
Rx0000034 | Genentech USA | 04/25/2024 | Alecensa 150 Mg - 240 Capsules | ||||
Rx0000034 | Genentech USA | 03/31/2024 | ENSPRYNG® (satralizumab-mwge) 120 mg/mL prefilled syringe | ||||
Rx0000034 | Genentech USA | 03/31/2024 | GAZYVA® (obinutuzumab) 1,000 mg/40 mL vial | ||||
Rx0000034 | Genentech USA | 07/24/2024 | KADCYLA® (ado-trastuzumab emtansine) 100 mg vial. Lyophilized powder in single-dose vials: 100 mg per vial of ado-trastuzumab emtansine. | ||||
Rx0000034 | Genentech USA | 07/24/2024 | KADCYLA® (ado-trastuzumab emtansine) 160 mg vial. Lyophilized powder in single-dose vials: 160 mg per vial of ado-trastuzumab emtansine. | ||||
Rx0000034 | Genentech USA | 03/31/2024 | KADCYLA® (ado-trastuzumab emtansine) 100 mg vial | ||||
Rx0000034 | Genentech USA | 03/31/2024 | KADCYLA® (ado-trastuzumab emtansine) 160 mg vial | ||||
Rx0000034 | Genentech USA | 03/31/2024 | PERJETA® (pertuzumab) 420 mg/14 mL vial | ||||
Rx0000034 | Genentech USA | 07/24/2024 | POLIVY® (polatuzumab vedotin-piiq) 140 mg Vial. POLIVY for injection is a sterile, preservative-free, white to grayish-white lyophilized powder, which has a cake-like appearance and is supplied in 140 mg single-dose vial. | ||||
Rx0000034 | Genentech USA | 07/24/2024 | POLIVY® (polatuzumab vedotin-piiq) 30 mg vial. POLIVY for injection is a sterile, preservative-free, white to grayish-white lyophilized powder, which has a cake-like appearance and is supplied in a 30 mg single-dose vial. | ||||
Rx0000034 | Genentech USA | 03/31/2024 | POLIVY® (polatuzumab vedotin-piiq) 30 mg vial | ||||
Rx0000034 | Genentech USA | 03/31/2024 | POLIVY® (polatuzumab vidotin-piiq) 140 mg vial | ||||
Rx0000034 | Genentech USA | 03/31/2024 | TNKase® (tenecteplase) 50 mg vial | ||||
Rx0000034 | Genentech USA | 07/24/2024 | TNKase® (tenecteplase) 50 mg vial. TNKase (tenecteplase for injection) is supplied as a sterile, lyophilized powder in a 50 mg, glass (20 cc) vial under partial vacuum. | ||||
Rx0000034 | Genentech USA | 03/31/2024 | XOLAIR® (omalizumab) 150 mg vial | ||||
Rx0000034 | Genentech USA | 03/31/2024 | XOLAIR® (omalizumab) 150 mg/mL syringe | ||||
Rx0000034 | Genentech USA | 03/31/2024 | XOLAIR® (omalizumab) 75 mg/0.5 mL syringe | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | BIKTARVY (bictegravir sodium/emtricitabine/tenofovir alafenamide fumar 30 mg-120 mg-15 mg) tablet, 30ct bottle | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | BIKTARVY (bictegravir sodium/emtricitabine/tenofovir alafenamide fumar 50 mg-200 mg-25 mg) tablet, 30ct blister pack | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | BIKTARVY (bictegravir sodium/emtricitabine/tenofovir alafenamide fumar 50 mg-200 mg-25 mg) tablet, 30ct bottle | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | CAYSTON (aztreonam for inhalation solution) 75mg/vial, 84 vials/kit | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | COMPLERA (emtricitabine/rilpivirine HCl/tenofovir disoproxil fumarate 200 mg-25 mg-300 mg) tablet, 30ct bottle | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | GENVOYA (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide 150 mg-150 mg-200 mg-10 mg) tablet, 30ct bottle | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | LETAIRIS (ambrisentan 10 mg) tablet, 10ct bottle | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | LETAIRIS (ambrisentan 10 mg) tablet, 30ct bottle | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | LETAIRIS (ambrisentan 5 mg) tablet, 10ct bottle | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | LETAIRIS (ambrisentan 5 mg) tablet, 30ct bottle | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | ODEFSEY (emtricitabine/rilpivirine HCl/tenofovir alafenamide fumarate 200 mg-25 mg-25 mg) tablet, 30ct bottle | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | STRIBILD (elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil 150 mg-150 mg-200 mg-300 mg) tablet, 30ct bottle | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | TYBOST (cobicistat 150 mg) tablet, 30ct bottle | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | VEMLIDY (tenofovir alafenamide 25mg) tablets, 30ct bottle | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | ZYDELIG (idelalisib 100 mg) tablet, 60ct bottle | ||||
Rx0000087 | Gilead Sciences, Inc. | 04/29/2024 | ZYDELIG (idelalisib 150 mg) tablet, 60ct bottle | ||||
Rx0000029 | GlaxoSmithKline | 04/19/2024 | Benlysta, Belimumab 200 MG/ML Solution Auto-injector 1 ML | ||||
Rx0000029 | GlaxoSmithKline | 04/19/2024 | Benlysta, Belimumab 200 MG/ML Solution Auto-injector 1 ML X4 | ||||
Rx0000029 | GlaxoSmithKline | 04/19/2024 | Benlysta, Belimumab 200 MG/ML Solution Prefilled Syringe 1 ML UD | ||||
Rx0000029 | GlaxoSmithKline | 04/19/2024 | Benlysta, Belimumab 200 MG/ML Solution Prefilled Syringe 1 ML UD X4 | ||||
Rx0000029 | GlaxoSmithKline | 04/19/2024 | Bexsero, Meningococcal Vac Group B (Recombant OMV Adjuvanted) Suspension Prefilled Syringe 0.5 ML UD | ||||
Rx0000029 | GlaxoSmithKline | 04/19/2024 | Bexsero, Meningococcal Vac Group B (Recombant OMV Adjuvanted) Suspension Prefilled Syringe 0.5 ML UD X10 | ||||
Rx0000029 | GlaxoSmithKline | 04/19/2024 | Nucala, Mepolizumab 100 MG/ML Solution Auto-injector 1 ML UD | ||||
Rx0000029 | GlaxoSmithKline | 04/19/2024 | Nucala, Mepolizumab 100 MG/ML Solution Prefilled Syringe 1 ML UD | ||||
Rx0000029 | GlaxoSmithKline | 04/19/2024 | Shingrix, Zoster Vaccine Recombinant Adjuvanted 50 MCG/0.5ML Suspension Reconstituted 1 EA UD | ||||
Rx0000029 | GlaxoSmithKline | 04/19/2024 | Shingrix, Zoster Vaccine Recombinant Adjuvanted 50 MCG/0.5ML Suspension Reconstituted 1 EA UD X10 | ||||
Rx0000164 | Harmony Biosciences, LLC | 04/24/2024 | WAKIX pitolisant HCl 17.8 mg 30 Oral Tab | ||||
Rx0000164 | Harmony Biosciences, LLC | 04/24/2024 | WAKIX pitolisant HCl 4.45 mg 30 Oral Tab | ||||
Rx0000534 | Harrow Eye, LLC | 04/24/2024 | Ilevro Ophthalmic Suspension 0.3 % | 04/26/2023 | Novartis | Product was purchased along with four other products, total deal value was up to $175M | |
Rx0000534 | Harrow Eye, LLC | 07/18/2024 | Natamycin Ophth Susp 5%, 15 ML, Unit-of-Use, Bottle | 10/12/2023 | Santen | Product was purchased with 6 other products total deal value was up to $20M | |
Rx0000534 | Harrow Eye, LLC | 04/24/2024 | Nevanac Ophthalmic Suspension 0.1 % | 04/26/2023 | Novartis | Product was purchased along with four other products, total deal value was up to $175M | |
Rx0000534 | Harrow Eye, LLC | 04/24/2024 | Triesence Intraocular Suspension 40 MG/ML | 01/20/2023 | Alcon | Product was purchased along with four other products, total deal value was up to $175M | |
Rx0000534 | Harrow Eye, LLC | 04/24/2024 | Verkazia Ophthalmic Emulsion 0.1 % | 10/19/2023 | Santen Pharmaceutical Co., Ltd | Product was purchased with 6 other products total deal value was up to $20M | |
Rx0000145 | Horizon Therapeutics USA, Inc. | 07/22/2024 | Product Name: KRYSTEXXA; Drug product strength: 1 mL sterile concentrate for dilution containing 8 mg of pegloticase protein, expressed in uricase protein amounts. Drug product dosage form: vial. Drug product package size: 8 MG/ML single use vial | ||||
Rx0000287 | Insmed Incorporated | 04/12/2024 | Arikayce Inhalation Suspension 590 MG/8.4ML | ||||
Rx0000266 | Intercept Pharmaceuticals, Inc. | 04/02/2024 | Ocaliva - OBETICHOLIC ACID - 10mg Oral Tablet, 30ct bottle [Qty:1] | ||||
Rx0000266 | Intercept Pharmaceuticals, Inc. | 04/02/2024 | Ocaliva - OBETICHOLIC ACID - 5mg Oral Tablet, 30ct bottle [Qty:1] | ||||
Rx0000214 | Intra-Cellular Therapies, Inc. | 04/02/2024 | Caplyta Oral Capsule 42 MG 30 Pack | ||||
Rx0000084 | Ipsen Biopharmaceuticals, Inc. | 10/02/2024 | Drug product name: Onivyde. Drug product strength: 43 mg/10 mL (4.3 mg/mL). Drug product dosage form: vial. Drug product package size: 10 mL. | ||||
Rx0000084 | Ipsen Biopharmaceuticals, Inc. | 03/31/2024 | Drug product name: Tazverik. Drug product strength: 200mg. Drug product dosage form: tablet. Drug product package size: 1 bottle (240 tablets). | 08/12/2022 | Epizyme, Inc. | For purposes of 22 CCR § 96070(b)(12)(c) (requirement to report the purchase price of the relevant drug, if the drug was acquired by the manufacturer within the previous five years), Ipsen purchased Epizyme, Inc. in August 2022, including Tazverik. The purchase price of the drug product (as Ipsen understands that data element) is not in the public domain or otherwise publicly available. However, information regarding Ipsens purchase of Epizyme, Inc. is available on p. 82, Note 1.2 of section 3.2.5 of the Registration Document located at: https://www.ipsen.com/websites/Ipsen_Online/wp-content/uploads/2023/04/06183729/EN_UNIVERSAL-REGISTRATION-DOCUMENT-2022-BD.pdf | |
Rx0000248 | Janssen Biotech, Inc. | 04/26/2024 | DARZALEX FASPRO (daratumumab and hyaluronidase-fihj)Strength: 1800mg / 15 mL Package Size:1 Form:1 single vial | ||||
Rx0000248 | Janssen Biotech, Inc. | 10/30/2024 | DARZALEX FASPRO (daratumumab and hyaluronidase-fihj)Strength: 1800mg / 15 mL Package Size:1 Form:1 single vial | ||||
Rx0000248 | Janssen Biotech, Inc. | 04/26/2024 | DARZALEX (daratumumab)Strength:100 mg 5 mL Package Size:1 Form:1 single vial | ||||
Rx0000248 | Janssen Biotech, Inc. | 10/30/2024 | DARZALEX (daratumumab)Strength:100 mg 5 mL Package Size:1 Form:1 single vial | ||||
Rx0000248 | Janssen Biotech, Inc. | 04/26/2024 | DARZALEX (daratumumab)Strength:400 mg 20 mL Package Size:1 Form:1 single vial | ||||
Rx0000248 | Janssen Biotech, Inc. | 10/30/2024 | DARZALEX (daratumumab)Strength:400 mg 20 mL Package Size:1 Form:1 single vial | ||||
Rx0000248 | Janssen Biotech, Inc. | 04/26/2024 | RYBREVANT (amivantamab-vmjw)Strength: 350mg/7mL Package Size:1 Form:1 single vial | ||||
Rx0000248 | Janssen Biotech, Inc. | 07/30/2024 | RYBREVANT (amivantamab-vmjw)Strength: 350mg/7mL Package Size:1 Form:1 single vial | ||||
Rx0000248 | Janssen Biotech, Inc. | 04/26/2024 | TREMFYA (guselkumab) One Press Injector Strength: 100mg / 1 mL Package Size:1 Form:1 syringe | ||||
Rx0000248 | Janssen Biotech, Inc. | 04/26/2024 | TREMFYA (guselkumab) prefilled syringe Strength: 100mg / 1 mL Package Size:1 Form:1 syringe | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | ELMIRON® Strength:100 mg Package Size:100 Form:Capsule | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | INVEGA® HAFYERA® Strength:1092 mg Package Size:1 Form:Disposable Syringe/Dose Pack | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | INVEGA® HAFYERA® Strength:1560 mg Package Size:1 Form:Disposable Syringe/Dose Pack | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | INVEGA® SUSTENNA® Strength:117 mg Package Size:1 Form:Disposable Syringe/Dose Pack | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | INVEGA® SUSTENNA® Strength:156 mg Package Size:1 Form:Disposable Syringe/Dose Pack | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | INVEGA® SUSTENNA® Strength:234 mg Package Size:1 Form:Disposable Syringe/Dose Pack | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | INVEGA® SUSTENNA® Strength:39 mg Package Size:1 Form:Disposable Syringe/Dose Pack | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | INVEGA® SUSTENNA® Strength:78 mg Package Size:1 Form:Disposable Syringe/Dose Pack | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | INVEGA® TRINZA® Strength:273 mg Package Size:1 Form:Disposable Syringe/Dose Pack | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | INVEGA® TRINZA® Strength:410 mg Package Size:1 Form:Disposable Syringe/Dose Pack | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | INVEGA® TRINZA® Strength:546 mg Package Size:1 Form:Disposable Syringe/Dose Pack | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | INVEGA® TRINZA® Strength:819 mg Package Size:1 Form:Disposable Syringe/Dose Pack | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 07/30/2024 | PONVORY ® (ponesimod) Strength: 10 mg Package Size:14 Form:Tablet | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 07/30/2024 | PONVORY ® (ponesimod) Strength: 20 mg Package Size:30 Form:Tablet | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | SPRAVATO Strength:56 mg Package Size:2 Form:Nasal Spray | ||||
Rx0000253 | Janssen Pharmaceuticals, Inc. | 04/26/2024 | SPRAVATO Strength:84 mg Package Size:3 Form:Nasal Spray | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | BALVERSA® (erdafitinib) Strength:3 MG Package Size:56 Form:Tablet | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | BALVERSA® (erdafitinib) Strength:3 MG Package Size:84 Form:Tablet | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | BALVERSA® (erdafitinib) Strength:4 MG Package Size:28 Form:Tablet | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | BALVERSA® (erdafitinib) Strength:4 MG Package Size:56 Form:Tablet | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | BALVERSA® (erdafitinib) Strength:5 MG Package Size:28 Form:Tablet | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | EDURANT (rilpivirine) Strength:25mg Package Size:30 Form:Tablet | ||||
Rx0000250 | Janssen Products, LP | 07/30/2024 | EDURANT (rilpivirine) Strength:25mg Package Size:30 Form:Tablet | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | ERLEADA (apalutamide) Strength:60mg Package Size:120 Form:Tablet | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | PREZCOBIX (darunavir 800mg, cobicistat 150mg) Strength:800 MG/150 MG Package Size:30 Form:Tablet | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | PREZISTA® Strength:150 MG Package Size:240 Form:Tablet | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | PREZISTA® Strength:600 MG Package Size:60 Form:Tablet | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | PREZISTA® Strength:75 MG Package Size:480 Form:Tablet | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | PREZISTA® Strength:800 MG Package Size:30 Form:Tablet | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | PREZISTA® ORAL SUSPENSION Strength:100MG/mL Package Size:200mL Form:Oral Suspension | ||||
Rx0000250 | Janssen Products, LP | 04/26/2024 | SYMTUZA (darunavir 800mg/cobicistat 150mg/emtricitabine 200mg/tenofovir alafenamide 10mg) Strength: 800 MG/150 MG/200 MG/10 MG Package Size:30 Form:Tablet | ||||
Rx0000008 | Jazz Pharmaceuticals, Inc. | 10/23/2024 | Defitelio (Defibrotide Sodium) Carton of 10 Vials | ||||
Rx0000008 | Jazz Pharmaceuticals, Inc. | 04/26/2024 | Defitelio 200mg/2.5mL Solution 80mg/1mL | ||||
Rx0000008 | Jazz Pharmaceuticals, Inc. | 10/23/2024 | RYLAZE (asparaginase erwinia chrysanthemi (recombinant)-rywn) injection - 3 vial pack | ||||
Rx0000008 | Jazz Pharmaceuticals, Inc. | 10/23/2024 | Vyxeos daunorubicin and cytarabine liposome for injection (2 vial carton) | ||||
Rx0000008 | Jazz Pharmaceuticals, Inc. | 04/26/2024 | Xyrem 500 MG/ML Oral Solution 180 ml | ||||
Rx0000008 | Jazz Pharmaceuticals, Inc. | 04/26/2024 | Xywav 500 MG/ML Oral Solution 180 ml | ||||
Rx0000008 | Jazz Pharmaceuticals, Inc. | 10/23/2024 | Zepzelca (lurbinectedin) 4mg Vial | 12/19/2019 | PharmaMar | 200000000 | |
Rx0000127 | Karyopharm Therapeutics Inc. | 04/25/2024 | Xpovio (100 MG Once Weekly) Oral Tablet Therapy Pack 50 MG, 2 Each, Unit-of-Use, Disp Pack Qty 4 | ||||
Rx0000127 | Karyopharm Therapeutics Inc. | 04/25/2024 | Xpovio (40 MG Once Weekly) Oral Tablet Therapy Pack 40 MG, 1 Each, Unit-of-Use, Disp Pack Qty 4 | ||||
Rx0000127 | Karyopharm Therapeutics Inc. | 04/25/2024 | Xpovio (40 MG Twice Weekly) Oral Tablet Therapy Pack 40 MG, 2 Each, Unit-of-Use, Disp Pack Qty 4 | ||||
Rx0000127 | Karyopharm Therapeutics Inc. | 04/25/2024 | Xpovio (60 MG Once Weekly) Oral Tablet Therapy Pack 60 MG, 1 Each, Unit-of-Use, Disp Pack Qty 4 | ||||
Rx0000127 | Karyopharm Therapeutics Inc. | 04/25/2024 | Xpovio (60 MG Twice Weekly) Oral Tablet Therapy Pack 20 MG, 6 Each, Unit-of-Use, Disp Pack Qty 4 | ||||
Rx0000127 | Karyopharm Therapeutics Inc. | 04/25/2024 | Xpovio (80 MG Once Weekly) Oral Tablet Therapy Pack 40 MG, 2 Each, Unit-of-Use, Disp Pack Qty 4 | ||||
Rx0000127 | Karyopharm Therapeutics Inc. | 04/25/2024 | Xpovio (80 MG Twice Weekly) Oral Tablet Therapy Pack 20 MG, 8 Each, Unit-of-Use, Disp Pack Qty 4 | ||||
Rx0000264 | Kedrion Biopharma Inc. | 03/31/2024 | gammaked 10% carton w/ 1 x 100ml vial | ||||
Rx0000264 | Kedrion Biopharma Inc. | 03/31/2024 | gammaked 10% carton w/ 1 x 200ml vial | ||||
Rx0000264 | Kedrion Biopharma Inc. | 03/31/2024 | gammaked 10% carton w/ 1 x 50ml vial | ||||
Rx0000386 | KVK Tech, Inc. | 04/09/2024 | Lomaira Oral Tablet 8 MG 90ct | ||||
Rx0000060 | Kyowa Kirin, Inc. | 04/23/2024 | CRYSVITA (burosumab-twza) injection, for subcutaneous use, 10 mg/mL, 1 ML, single dose vial | ||||
Rx0000060 | Kyowa Kirin, Inc. | 04/23/2024 | CRYSVITA (burosumab-twza) injection, for subcutaneous use, 20 mg/mL, 1 ML, single dose vial | ||||
Rx0000060 | Kyowa Kirin, Inc. | 04/23/2024 | CRYSVITA (burosumab-twza) injection, for subcutaneous use, 30 mg/mL, 1 ML, single dose vial | ||||
Rx0000060 | Kyowa Kirin, Inc. | 04/23/2024 | Nourianz Oral Tablet 20 MG, 90 Each, Bottle | ||||
Rx0000060 | Kyowa Kirin, Inc. | 04/23/2024 | Nourianz Oral Tablet 40 MG, 90 Each, Bottle | ||||
Rx0000083 | Laboratoire HRA Pharma | 06/17/2024 | Lysodren 500 mg tablets 100 count bottles | ||||
Rx0000083 | Laboratoire HRA Pharma | 06/17/2024 | Metopirone 250 mg capsules 18 count bottles | ||||
Rx0000089 | Lannett Company, Inc. | 10/30/2024 | Lisdexamfetamine Dimesylate 40mg Capsule 100 CT Bottle | ||||
Rx0000089 | Lannett Company, Inc. | 10/30/2024 | Lisdexamfetamine Dimesylate 50mg Capsule 100 CT Bottle | ||||
Rx0000089 | Lannett Company, Inc. | 10/30/2024 | Lisdexamfetamine Dimesylate 60mg Capsule 100 CT Bottle | ||||
Rx0000089 | Lannett Company, Inc. | 10/30/2024 | Lisdexamfetamine Dimesylate 70mg Capsule 100 CT Bottle | ||||
Rx0000009 | Lantheus Medical Imaging, Inc. | 04/12/2024 | DEFINITY US 16Vial KIT. INJECTION, SUSPENSION, 6.52 mg/mL. 16 VIAL, GLASS in 1 CARTON (11994-011-16) > 1.5 mL in 1 VIAL, GLASS | ||||
Rx0000009 | Lantheus Medical Imaging, Inc. | 04/12/2024 | DEFINITY US 4Vial KIT. INJECTION, SUSPENSION, 6.52 mg/mL. 4 VIAL, GLASS in 1 CARTON (11994-011-04) > 1.5 mL in 1 VIAL, GLASS | ||||
Rx0000009 | Lantheus Medical Imaging, Inc. | 04/12/2024 | NEUROLITE® (Kit for the Preparation of Technetium Tc99m Bicisate for Injection) | ||||
Rx0000413 | Leadiant Biosciences, Inc. | 04/29/2024 | Cystaran Ophthalmic Solution 0.44 % | ||||
Rx0000025 | Lundbeck LLC | 04/23/2024 | Northera 100mg. 90 Capsules | ||||
Rx0000025 | Lundbeck LLC | 04/23/2024 | Northera 200mg. 90 Capsules | ||||
Rx0000025 | Lundbeck LLC | 04/23/2024 | Northera 300mg. 90 Capsules | ||||
Rx0000025 | Lundbeck LLC | 04/23/2024 | Onfi 10mg. 100 Tablets | ||||
Rx0000025 | Lundbeck LLC | 04/23/2024 | Onfi 20mg. 100 Tablets | ||||
Rx0000025 | Lundbeck LLC | 04/23/2024 | Onfi Oral Suspension 2.5mg/mL 120mL Bottle | ||||
Rx0000025 | Lundbeck LLC | 10/24/2024 | Vyepti 100mg/ml single dose vial | ||||
Rx0000025 | Lundbeck LLC | 04/23/2024 | Xenazine 12.5mg. 112 Tablets | ||||
Rx0000025 | Lundbeck LLC | 04/23/2024 | Xenazine 25.0mg. 112 Tablets | ||||
Rx0000072 | Mayne Pharma Inc | 07/26/2024 | Rhofade External Cream 1 %, 30 g, Unit-of-Use, Tube | 09/04/2023 | EPI Health LLC | 8000000 | Mayne Pharma completed the acquisition of the global rights to RHOFADE® from Novan Inc. and EPI Health, LLC on September 4, 2023. |
Rx0000382 | Melinta Therapeutics, LLC | 04/30/2024 | MINOCIN (Minocycline-Hydrochloride) is administered via intravenous form and packaged as 10 VIAL in 1 CARTON > 1 INJECTION in 1 VIAL (100 mg dose) | ||||
Rx0000138 | Merck Sharp & Dohme LLC | 04/23/2024 | BRIDION 10 200 mg/2 mL Vial (ML) | ||||
Rx0000138 | Merck Sharp & Dohme LLC | 04/23/2024 | BRIDION 10 500 mg/5 mL Vial (ML) | ||||
Rx0000138 | Merck Sharp & Dohme LLC | 04/23/2024 | DIFICID 1 packet granules (40mg/mL final concentration) Suspension-Reconsitituted-Oral (EA) | ||||
Rx0000138 | Merck Sharp & Dohme LLC | 04/23/2024 | DIFICID 20 200 mg Tablets | ||||
Rx0000138 | Merck Sharp & Dohme LLC | 09/26/2024 | GARDASIL 9 0.5 mL Syringes 10 | ||||
Rx0000138 | Merck Sharp & Dohme LLC | 09/26/2024 | GARDASIL 9 0.5 mL Vials 10 | ||||
Rx0000138 | Merck Sharp & Dohme LLC | 09/26/2024 | VARIVAX 0.5 mL Vials 10 | ||||
Rx0000138 | Merck Sharp & Dohme LLC | 04/23/2024 | ZERBAXA 10 1.5 gram Vial (EA) | ||||
Rx0000051 | MILLICENT U.S., INC. | 04/25/2024 | Femring (estradiol acetate vaginal ring) 0.1 mg/day, 1 Box | ||||
Rx0000051 | MILLICENT U.S., INC. | 04/25/2024 | Femring (estradiol acetate vaginal ring) 0.05 mg/day, 1 Box | ||||
Rx0000051 | MILLICENT U.S., INC. | 04/25/2024 | Intrarosa Prasterone Vaginal Inserts 6.5 mg per insert, 28 inserts per box | 05/01/2020 | AMAG | 20000000 | |
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Cimduo Tabs 300mg/300mg 30s | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Depen (Penicillamine Tabs) 250mg 1s | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Edluar 10mg Sublingual T 3x10 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Edluar 10mg Sublingual T 5x6 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Edluar 5mg Sublingual T 3x10 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Edluar 5mg Sublingual T 5x6 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | EMSAM TDS 12mg/day Bx30 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | EMSAM TDS 6mg/day Bx30 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | EMSAM TDS 9mg/day Bx30 | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Epifoam 1% 10g 1PK | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Gastrocrom Oral Concentrate 20mg/mL 5mL 96s | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Levsin Tabs 0.125mg 100s | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Levsin/SL Tabs 0.125mg 100s | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | NuLev Chewable Melt Tabs 0.125mg 100s | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Pretomanid Tabs 200mg 26s | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Proctofoam HC 1% 10g 1PK | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Proctofoam NS 1% 15g | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Rowasa Kit Rectal Suspension 4g/60mL 28PK | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Rowasa Kit Rectal Suspension 4g/60mL 7PK | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Soma Tabs 250mg 30s | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Soma Tabs 250mg100s | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Soma Tabs 350mg 100s | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Symfi Lo Tabs 400mg/300mg/300mg 30s | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Symfi Tabs 600mg/300mg/300mg 30s | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Tobramycin Inhalation Solution (Tobi) 300mg/5mL 56s | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | Urelle Tabs 0.12mg/81mg/10.8mg/32.4mg/40.8mg 90s | ||||
Rx0000046 | Mylan Specialty LP | 10/31/2024 | YUPELRI (Revefenacin) Inhalation Solution 175mcg/3mL 30PK | ||||
Rx0000046 | Mylan Specialty LP | 04/30/2024 | YUPELRI Inhalation Solution 175mcg/3mL | ||||
Rx0000476 | Neurelis | 03/31/2024 | 1 VALTOCO CARTON .5mg/.1ml VIAL, 1 Each, Unit-of-Use, Box Qty 2 | ||||
Rx0000476 | Neurelis | 03/31/2024 | 1 VALTOCO CARTON 10mg/.1ml VIAL, 1 Each, Unit-of-Use, Box Qty 2 | ||||
Rx0000476 | Neurelis | 03/31/2024 | VALTOCO CARTON with 10mg/.1ml VIALS, 1 Each, Unit-of-Use, Box Qty 2 | ||||
Rx0000476 | Neurelis | 03/31/2024 | VALTOCO CARTON with 7.5mg/.1ml VIALS, 1 Each, Unit-of-Use, Box Qty 2 | ||||
Rx0000420 | Nielsen BioSciences, Inc. | 03/31/2024 | Candin Injection Solution/1U in 0.1mL Intradermally/1mL Vial | ||||
Rx0000420 | Nielsen BioSciences, Inc. | 03/31/2024 | Spherusol Injection Solution/Coccidioides immitis Spherule-Derived Skin Test Antigen - 1.27mcg/0.1mL/1mL Vial/0.1mL Intradermally/1ml multidose vial | ||||
Rx0000204 | Noden Pharma USA, Inc. | 03/31/2024 | TEKTURNA 150MG TAB 30/EA | ||||
Rx0000204 | Noden Pharma USA, Inc. | 03/31/2024 | TEKTURNA 300MG TAB 30/EA | ||||
Rx0000073 | Novartis | 04/26/2024 | AFINITOR DISPERZ TABLET FOR SUSPENSION 2 mg 28 | ||||
Rx0000073 | Novartis | 04/26/2024 | AFINITOR DISPERZ TABLET FOR SUSPENSION 3 mg 28 | ||||
Rx0000073 | Novartis | 04/26/2024 | AFINITOR DISPERZ TABLET FOR SUSPENSION 5 mg 28 | ||||
Rx0000073 | Novartis | 04/26/2024 | AFINITOR TABLET 10 mg 28 | ||||
Rx0000073 | Novartis | 04/26/2024 | AFINITOR TABLET 2.5 mg 28 | ||||
Rx0000073 | Novartis | 04/26/2024 | AFINITOR TABLET 5 mg 28 | ||||
Rx0000073 | Novartis | 04/26/2024 | AFINITOR TABLET 7.5 mg 28 | ||||
Rx0000073 | Novartis | 04/26/2024 | COSENTYX (2 SYRINGES) SYRINGE (ML) 150 mg/mL 1 | ||||
Rx0000073 | Novartis | 04/26/2024 | COSENTYX SENSOREADY (2 PENS) PEN INJECTOR (ML) 150 mg/mL 1 | ||||
Rx0000073 | Novartis | 04/26/2024 | COSENTYX SENSOREADY PEN PEN INJECTOR (ML) 150 mg/mL 1 | ||||
Rx0000073 | Novartis | 04/26/2024 | COSENTYX SYRINGE SYRINGE (ML) 150 mg/mL 1 | ||||
Rx0000073 | Novartis | 04/26/2024 | COSENTYX SYRINGE SYRINGE (ML) 75 mg/0.5 mL 0.5 | ||||
Rx0000073 | Novartis | 04/26/2024 | DIOVAN HCT TABLET 160 mg-12.5 mg 90 | ||||
Rx0000073 | Novartis | 04/26/2024 | DIOVAN HCT TABLET 160 mg-25 mg 90 | ||||
Rx0000073 | Novartis | 04/26/2024 | DIOVAN HCT TABLET 320 mg-12.5 mg 90 | ||||
Rx0000073 | Novartis | 04/26/2024 | DIOVAN HCT TABLET 320 mg-25 mg 90 | ||||
Rx0000073 | Novartis | 04/26/2024 | DIOVAN HCT TABLET 80 mg-12.5 mg 90 | ||||
Rx0000073 | Novartis | 04/26/2024 | DIOVAN TABLET 160 mg 90 | ||||
Rx0000073 | Novartis | 04/26/2024 | DIOVAN TABLET 320 mg 90 | ||||
Rx0000073 | Novartis | 04/26/2024 | DIOVAN TABLET 40 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | DIOVAN TABLET 80 mg 90 | ||||
Rx0000073 | Novartis | 04/26/2024 | ENTRESTO TABLET 24 mg-26 mg 180 | ||||
Rx0000073 | Novartis | 04/26/2024 | ENTRESTO TABLET 24 mg-26 mg 60 | ||||
Rx0000073 | Novartis | 04/26/2024 | ENTRESTO TABLET 49 mg-51 mg 180 | ||||
Rx0000073 | Novartis | 04/26/2024 | ENTRESTO TABLET 49 mg-51 mg 60 | ||||
Rx0000073 | Novartis | 04/26/2024 | ENTRESTO TABLET 97 mg-103 mg 180 | ||||
Rx0000073 | Novartis | 04/26/2024 | ENTRESTO TABLET 97 mg-103 mg 60 | ||||
Rx0000073 | Novartis | 04/26/2024 | EXFORGE HCT TABLET 10 mg-160 mg-12.5 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | EXFORGE HCT TABLET 10 mg-160 mg-25 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | EXFORGE HCT TABLET 10 mg-320 mg-25 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | EXFORGE HCT TABLET 5 mg-160 mg-12.5 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | EXFORGE HCT TABLET 5 mg-160 mg-25 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | EXFORGE TABLET 10 mg-160 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | EXFORGE TABLET 10 mg-320 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | EXFORGE TABLET 5 mg-160 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | EXFORGE TABLET 5 mg-320 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | EXJADE TABLET, DISPERSIBLE 125 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | EXJADE TABLET, DISPERSIBLE 250 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | EXJADE TABLET, DISPERSIBLE 500 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | EXTAVIA KIT 0.3 mg 15 | ||||
Rx0000073 | Novartis | 04/26/2024 | GILENYA CAPSULE 0.5 mg 30 | ||||
Rx0000073 | Novartis | 10/31/2024 | ILARIS VIAL (ML) 150 mg/mL 1 VIAL | ||||
Rx0000073 | Novartis | 04/26/2024 | JADENU SPRINKLE GRANULES IN PACKET (EA) 180 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | JADENU SPRINKLE GRANULES IN PACKET (EA) 360 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | JADENU SPRINKLE GRANULES IN PACKET (EA) 90 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | JADENU TABLET 180 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | JADENU TABLET 360 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | JADENU TABLET 90 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | KESIMPTA PEN PEN INJECTOR (ML) 20 mg/0.4 mL 0.4 | ||||
Rx0000073 | Novartis | 04/26/2024 | KISQALI FEMARA CO-PACK TABLET 200 mg/day (200 mg x 1)-2.5 mg 49 | ||||
Rx0000073 | Novartis | 04/26/2024 | KISQALI FEMARA CO-PACK TABLET 400 mg/day (200 mg x 2)-2.5 mg 70 | ||||
Rx0000073 | Novartis | 04/26/2024 | KISQALI FEMARA CO-PACK TABLET 600 mg/day (200 mg x 3)-2.5 mg 91 | ||||
Rx0000073 | Novartis | 04/26/2024 | KISQALI TABLET 200 mg/day (200 mg x 1) 21 | ||||
Rx0000073 | Novartis | 04/26/2024 | KISQALI TABLET 400 mg/day (200 mg x 2) 42 | ||||
Rx0000073 | Novartis | 04/26/2024 | KISQALI TABLET 600 mg/day (200 mg x 3) 63 | ||||
Rx0000073 | Novartis | 07/31/2024 | KYMRIAH PLASTIC BAG, INJECTION (EA) 0.2 x 10exp6 to 2.5 x 10exp8 cell 1 | ||||
Rx0000073 | Novartis | 07/31/2024 | KYMRIAH PLASTIC BAG, INJECTION (EA) 0.6 x 10exp8 to 6 x 10exp8 cell 1 | ||||
Rx0000073 | Novartis | 04/26/2024 | MAYZENT TABLET 0.25 mg 28 | ||||
Rx0000073 | Novartis | 04/26/2024 | MAYZENT TABLET 2 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | MAYZENT TABLET, DOSE PACK 0.25 mg (12 tabs) 12 | ||||
Rx0000073 | Novartis | 04/26/2024 | MEKINIST TABLET 0.5 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | MEKINIST TABLET 2 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | MYFORTIC TABLET, DELAYED RELEASE (ENTERIC COATED) 180 mg 120 | ||||
Rx0000073 | Novartis | 04/26/2024 | MYFORTIC TABLET, DELAYED RELEASE (ENTERIC COATED) 360 mg 120 | ||||
Rx0000073 | Novartis | 04/26/2024 | NEORAL CAPSULE 100 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | NEORAL CAPSULE 25 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | NEORAL SOLUTION, ORAL 100 mg/mL 50 | ||||
Rx0000073 | Novartis | 04/26/2024 | PIQRAY TABLET 200 mg/day (200 mg x 1) 28 | ||||
Rx0000073 | Novartis | 04/26/2024 | PIQRAY TABLET 250 mg/day (200 mg x 1 and 50 mg x 1) 56 | ||||
Rx0000073 | Novartis | 04/26/2024 | PIQRAY TABLET 300 mg/day (150 mg x 2) 56 | ||||
Rx0000073 | Novartis | 04/26/2024 | PROMACTA POWDER IN PACKET (EA) 12.5 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | PROMACTA POWDER IN PACKET (EA) 25 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | PROMACTA TABLET 12.5 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | PROMACTA TABLET 25 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | PROMACTA TABLET 50 mg 14 | ||||
Rx0000073 | Novartis | 04/26/2024 | PROMACTA TABLET 50 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | PROMACTA TABLET 75 mg 30 | ||||
Rx0000073 | Novartis | 04/26/2024 | RYDAPT CAPSULE 25 mg 112 | ||||
Rx0000073 | Novartis | 04/26/2024 | RYDAPT CAPSULE 25 mg 56 | ||||
Rx0000073 | Novartis | 04/26/2024 | SCEMBLIX TABLET 20 mg 60 | ||||
Rx0000073 | Novartis | 04/26/2024 | SCEMBLIX TABLET 40 mg 60 | ||||
Rx0000073 | Novartis | 04/26/2024 | TABRECTA TABLET 150 mg 56 | ||||
Rx0000073 | Novartis | 04/26/2024 | TABRECTA TABLET 200 mg 56 | ||||
Rx0000073 | Novartis | 04/26/2024 | TAFINLAR CAPSULE 50 mg 120 | ||||
Rx0000073 | Novartis | 04/26/2024 | TAFINLAR CAPSULE 75 mg 120 | ||||
Rx0000073 | Novartis | 04/26/2024 | TASIGNA CAPSULE 150 mg 28 | ||||
Rx0000073 | Novartis | 04/26/2024 | TASIGNA CAPSULE 200 mg 28 | ||||
Rx0000073 | Novartis | 04/26/2024 | TASIGNA CAPSULE 50 mg 120 | ||||
Rx0000073 | Novartis | 04/26/2024 | TEGRETOL SUSPENSION, ORAL (FINAL DOSE FORM) 100 mg/5 mL 450 | ||||
Rx0000073 | Novartis | 04/26/2024 | TEGRETOL TABLET 200 mg 100 | ||||
Rx0000073 | Novartis | 04/26/2024 | TEGRETOL XR TABLET, EXTENDED RELEASE 12 HR 100 mg 100 | ||||
Rx0000073 | Novartis | 04/26/2024 | TEGRETOL XR TABLET, EXTENDED RELEASE 12 HR 200 mg 100 | ||||
Rx0000073 | Novartis | 04/26/2024 | TEGRETOL XR TABLET, EXTENDED RELEASE 12 HR 400 mg 100 | ||||
Rx0000073 | Novartis | 04/26/2024 | TOBRADEX OINTMENT (GRAM) 0.3 %-0.1 % 3.5 | ||||
Rx0000073 | Novartis | 04/26/2024 | TRILEPTAL SUSPENSION, ORAL (FINAL DOSE FORM) 300 mg/5 mL (60 mg/mL) 250 | ||||
Rx0000073 | Novartis | 04/26/2024 | TRILEPTAL TABLET 150 mg 100 | ||||
Rx0000073 | Novartis | 04/26/2024 | TRILEPTAL TABLET 300 mg 100 | ||||
Rx0000073 | Novartis | 04/26/2024 | TRILEPTAL TABLET 600 mg 100 | ||||
Rx0000073 | Novartis | 04/26/2024 | TYKERB TABLET 250 mg 150 | ||||
Rx0000073 | Novartis | 04/26/2024 | ZYKADIA TABLET 150 mg 84 | ||||
Rx0000249 | Octapharma USA, Inc. | 07/31/2024 | Panzyga 10 gm/100 mL single use vial | ||||
Rx0000249 | Octapharma USA, Inc. | 07/31/2024 | Panzyga 2.5 gm/ 25 mL single use vial | ||||
Rx0000249 | Octapharma USA, Inc. | 07/31/2024 | Panzyga 20 gm/200 mL single use vial | ||||
Rx0000249 | Octapharma USA, Inc. | 07/31/2024 | Panzyga 30 gm/300 mL single use vial | ||||
Rx0000249 | Octapharma USA, Inc. | 07/31/2024 | Panzyga 5 gm/50 mL single use vial | ||||
Rx0000375 | Organon | 07/18/2024 | Pregnyl Intramuscular Solution Reconstituted 10000 Unit Package of 1 Vial | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Abilify Asimtufii 720mg Kit | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Abilify Asimtufii 960mg Kit | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Abilify Maintena 300mg Dual Chamber Syringe | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Abilify Maintena 300mg Kit | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Abilify Maintena 400mg Dual Chamber Syringe | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Abilify Maintena 400mg Kit | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Jynarque 15mg tablets, 30 count bottle | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Jynarque 15mg/15mg tablets, 4x weekly blister cards | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Jynarque 30mg tablets, 30 count bottle | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Jynarque 30mg/15mg tablets, 4x weekly blister cards | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Jynarque 45mg/15mg tablets, 4x weekly blister cards | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Jynarque 60mg/30mg tablets, 4x weekly blister cards | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Jynarque 90mg/30mg tablets, 4x weekly blister cards | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Nuedexta 20mg/10mg CP, 60 count bottle | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Rexulti 0.25mg tablets, 30 count bottle | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Rexulti 0.5mg tablets, 30 count bottle | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Rexulti 1mg tablets, 30 count bottle | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Rexulti 2mg tablets, 30 count bottle | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Rexulti 3mg tablets, 30 count bottle | ||||
Rx0000067 | Otsuka America Pharmaceutical, Inc. | 04/30/2024 | Rexulti 4mg tablets, 30 count bottle | ||||
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 10 MG/0.4ML 1 Syringe | 12/15/2021 | Antares Pharma Inc. | 44021327 | |
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 10 MG/0.4ML 4 Syringe | 12/15/2021 | Antares Pharma Inc. | 44021327 | |
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 12.5 MG/0.4ML 1 Syringe | 12/15/2021 | Antares Pharma Inc. | 44021327 | |
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 12.5 MG/0.4ML 4 Syringe | 12/15/2021 | Antares Pharma Inc. | 44021327 | |
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 15 MG/0.4ML 1 Syringe | 12/15/2021 | Antares Pharma Inc. | 44021327 | |
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 15 MG/0.4ML 4 Syringe | 12/15/2021 | Antares Pharma Inc. | 44021327 | |
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 17.5 MG/0.4ML 1 Syringe | 12/15/2021 | Antares Pharma Inc. | 44021327 | |
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 17.5 MG/0.4ML 4 Syringe | 12/15/2021 | Antares Pharma Inc. | 44021327 | |
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 20 MG/0.4ML 1 Syringe | 12/15/2021 | Antares Pharma Inc. | 44021327 | |
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 20 MG/0.4ML 4 Syringe | 12/15/2021 | Antares Pharma Inc. | 44021327 | |
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 22.5 MG/0.4ML 1 Syringe | 12/15/2021 | Antares Pharma Inc. | 44021327 | |
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 22.5 MG/0.4ML 4 Syringe | 12/15/2021 | Antares Pharma Inc. | 44021327 | |
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 25 MG/0.4ML 1 Syringe | 12/15/2021 | Antares Pharma Inc. | 44021327 | |
Rx0000495 | Otter Pharmaceuticals LLC | 07/24/2024 | Otrexup Subcutaneous Solution Auto-injector 25 MG/0.4ML 4 Syringe | 12/15/2021 | Antares Pharma Inc. | 44021327 | |
Rx0000484 | Pacira Pharmaceuticals, Inc. | 04/18/2024 | EXPAREL 13.3mg/mL Injection Suspension Liposomal 10 vials in 1 carton | ||||
Rx0000484 | Pacira Pharmaceuticals, Inc. | 04/18/2024 | EXPAREL 13.3mg/mL Injection Suspension Liposomal 4 vials in 1 carton | ||||
Rx0000053 | Paratek Pharmaceuticals, Inc. | 10/17/2024 | Nuzyra 100mg/5mL Intravenous Injection; Powder; Lyophilized 10 Carton | ||||
Rx0000006 | Pfizer | 04/29/2024 | Acetylcysteine Solution Rx, 100 mg/mL (10 %), VIAL (ML), 30 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Acetylcysteine Solution Rx, 200 mg/mL (20 %), VIAL (ML), 30 | ||||
Rx0000006 | Pfizer | 04/29/2024 | ADD-Vantage, ADDapter Connector, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Aminophylline Injection Rx, 250 mg/10 mL, VIAL (ML), 10 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Antivenin (micrurus fulvius equine origin), 10mL, VIAL (ML), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | ATGAM (lymphocyte immune globulin,antithymocyte (equine)), 50 mg/mL, Ampul(ML), 5 | ||||
Rx0000006 | Pfizer | 04/29/2024 | ATROPINE SULFATE (atropine sulfate), 0.05 mg/mL, SYRINGE (ML), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | ATROPINE SULFATE (atropine sulfate), 0.1 mg/mL, SYRINGE (ML), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | ATROPINE SULFATE (atropine sulfate), 0.1 mg/mL, SYRINGE (ML), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BeneFIX® (coagulation factor IX (recombinant)) Lyophilized Powder for Reconstitution Rx, 1000 unit, VIAL (EA), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BeneFIX® (coagulation factor IX (recombinant)) Lyophilized Powder for Reconstitution Rx, 2000 unit, VIAL (EA), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BeneFIX® (coagulation factor IX (recombinant)) Lyophilized Powder for Reconstitution Rx, 250 unit, VIAL (EA), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BeneFIX® (coagulation factor IX (recombinant)) Lyophilized Powder for Reconstitution Rx, 3000 unit, VIAL (EA), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BeneFIX® (coagulation factor IX (recombinant)) Lyophilized Powder for Reconstitution Rx, 500 unit, VIAL (EA), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BICILLIN C-R (penicillin G benzathine/penicillin G procaine), 1,200,000 unit/2 mL (600,000/600,000), SYRINGE (ML), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BICILLIN C-R (penicillin G benzathine/penicillin G procaine), 1,200,000 unit/2 mL (600,000/600,000), SYRINGE (ML), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BICILLIN C-R (penicillin G benzathine/penicillin G procaine), 1,200,000 unit/2 mL (900,000/300,000), SYRINGE (ML), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BICILLIN L-A (penicillin G benzathine), 1.2 million unit/2 mL, SYRINGE (ML), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BICILLIN L-A (penicillin G benzathine), 2.4 million unit/4 mL, SYRINGE (ML), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BICILLIN L-A (penicillin G benzathine), 600,000 unit/mL, SYRINGE (ML), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BOSULIF (bosutinib), 100 mg, TABLET, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BOSULIF (bosutinib), 400 mg, TABLET, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BOSULIF (bosutinib), 500 mg, TABLET, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | BRAFTOVI (encorafenib), 75 mg, CAPSULE, 120 | 07/30/2019 | Array BioPharma Inc. | 11200000000 | On July 30, 2019, we acquired Array, a commercial stage biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule medicines to treat cancer and other diseases of high unmet need, for $48 per share in cash. The total fair value of the consideration transferred was $11.2 billion ($10.9 billion, net of cash acquired). In addition, $157 million in payments to Array employees for the fair value of previously unvested stock options was recognized as post-closing compensation expense and recorded in Restructuring charges and certain acquisition-related costs. |
Rx0000006 | Pfizer | 04/29/2024 | BRAFTOVI (encorafenib), 75 mg, CAPSULE, 180 | 07/30/2019 | Array BioPharma Inc. | 11200000000 | On July 30, 2019, we acquired Array, a commercial stage biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule medicines to treat cancer and other diseases of high unmet need, for $48 per share in cash. The total fair value of the consideration transferred was $11.2 billion ($10.9 billion, net of cash acquired). In addition, $157 million in payments to Array employees for the fair value of previously unvested stock options was recognized as post-closing compensation expense and recorded in Restructuring charges and certain acquisition-related costs. |
Rx0000006 | Pfizer | 04/29/2024 | Butorphanol Tartrate Injection - Controlled Substance - SCHEDULE IV Rx, 1 mg/mL (1 mg/mL) Single Dose Glass Fliptop Vial, 10 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Butorphanol Tartrate Injection - Controlled Substance - SCHEDULE IV Rx, 2 mg/mL (2 mg/mL) Single Dose Glass Fliptop Vial, 10 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Butorphanol Tartrate Injection - Controlled Substance - SCHEDULE IV Rx, 2 mg/mL (4 mg/2 mL) Single Dose Glass Fliptop Vial, 10 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Cerebyx® (fosphenytoin sodium) Injection Rx, 100 mg PE/2 mL Vial, 25 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Cerebyx® (fosphenytoin sodium) Injection Rx, 500 mg PE/10 mL Vial, 10 | ||||
Rx0000006 | Pfizer | 04/29/2024 | COPPER CHLORIDE (cupric chloride), 0.4 mg/mL, VIAL (ML), 25 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Demerol (meperidine hydrochloride) Injection - Controlled Substance - SCHEDULE II Rx, 50 mg/mL (1,500 mg/30 mL) Multiple Dose Glass Fliptop Vial, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | DEPO-ESTRADIOL (estradiol cypionate), 5 mg/mL, VIAL (ML), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Dextran (dextran) Injection Rx, 500 mL (10% LMD in 0.9% Sodium Chloride), Intravenous solution, 12 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Dextran (dextran) Injection Rx, 500 mL (10% LMD in 5% Dextrose), Intravenous solution, 12 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Diazepam Injection - Controlled Substance - SCHEDULE IV Rx, 5 mg/mL, VIAL (ML), 10 | ||||
Rx0000006 | Pfizer | 04/29/2024 | DOPAMINE HCL (dopamine HCl), 200 mg/5 mL (40 mg/mL), VIAL (ML), 25 | ||||
Rx0000006 | Pfizer | 04/29/2024 | DOPAMINE HCL (dopamine HCl), 400 mg/10 mL (40 mg/mL), VIAL (ML), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Epinephrine Injection Rx, 1mg/10mL (0.1 mg/mL) ABBOJECT Single-dose syringe, 10 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Gemcitabine Injection (Lyophilized) Rx, 200 mg, VIAL (EA), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Gentamicin Sulfate Injection Rx, 40 mg/mL (80 mg/2 mL) Single Dose Glass Fliptop Vial, 25 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Heparin Sodium (0.45% Sodium Chloride) Injection Rx, 100 Units/mL (25,000 Units/250 mL) Flexible Container, 24 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Heparin Sodium (0.45% Sodium Chloride) Injection Rx, 12500 unit/250 mL, INTRAVENOUS SOLUTION, 250 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Heparin Sodium (0.45% Sodium Chloride) Injection Rx, 25000 unit/250 mL (100 unit/mL), INTRAVENOUS SOLUTION, 250 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Heparin Sodium (0.45% Sodium Chloride) Injection Rx, 25000 unit/500 mL (50 unit/mL), INTRAVENOUS SOLUTION, 500 | ||||
Rx0000006 | Pfizer | 04/29/2024 | HEXTEND LACTATED ELECTROLYTE (hetastarch/electrolyte solution,lactated), 500mL, Vial, 12 | ||||
Rx0000006 | Pfizer | 04/29/2024 | IBRANCE (palbociclib), 100 mg, CAPSULE, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | IBRANCE (palbociclib), 100 mg, TABLET, 21 | ||||
Rx0000006 | Pfizer | 04/29/2024 | IBRANCE (palbociclib), 125 mg, CAPSULE, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | IBRANCE (palbociclib), 125 mg, TABLET, 21 | ||||
Rx0000006 | Pfizer | 04/29/2024 | IBRANCE (palbociclib), 75 mg, CAPSULE, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | IBRANCE (palbociclib), 75 mg, TABLET, 21 | ||||
Rx0000006 | Pfizer | 04/29/2024 | INLYTA (axitinib), 1 mg, TABLET, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | INLYTA (axitinib), 5 mg, TABLET, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | LIDOCAINE HCL (lidocaine HCl/PF), 50 mg/5 mL (1 %), SYRINGE (ML), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | LIDOCAINE HCL (lidocaine HCl/PF), 50 mg/5 mL (1 %), SYRINGE (ML), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | LORBRENA (lorlatinib), 100 mg, TABLET, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | LORBRENA (lorlatinib), 25 mg, TABLET, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | MAGNESIUM SULFATE (magnesium sulfate), 4 mEq/mL (50 %), SYRINGE (ML), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | MANGANESE CHLORIDE (manganese chloride), 0.1 mg/mL, VIAL (ML), 25 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Mannitol Injection Rx, 25% (12.5 g/50 mL), Vial, 25 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Marcaine with Epinephrine 1:200,000 as the bitartrate (bupivacaine hydrochloride & epinephrine) Injection Rx, 2.5 mg/mL (25 mg/10 mL), Vial, 10 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Marcaine with Epinephrine 1:200,000 as the bitartrate (bupivacaine hydrochloride & epinephrine) Injection Rx, 2.5 mg/mL (75 mg/30 mL), Vial, 10 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Marcaine with Epinephrine 1:200,000 as the bitartrate (bupivacaine hydrochloride & epinephrine) Injection Rx, 5 mg/mL (50 mg/10 mL), Vial, 10 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Marcaine (bupivacaine hydrochloride and epinephrine) Injection for NovaPlus, 2.5 mg/mL (0.25 %)-1:200000, VIAL (ML), 10 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Marcaine (bupivacaine hydrochloride and epinephrine) Injection for NovaPlus, 2.5 mg/mL (0.25 %)-1:200000, VIAL (ML), 30 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Marcaine (bupivacaine hydrochloride) Injection Rx, 2.5 mg/mL, VIAL (ML), 10 | ||||
Rx0000006 | Pfizer | 04/29/2024 | MEKTOVI (binimetinib), 15 mg, TABLET, 180 | 07/30/2019 | Array BioPharma Inc. | 11200000000 | On July 30, 2019, we acquired Array, a commercial stage biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule medicines to treat cancer and other diseases of high unmet need, for $48 per share in cash. The total fair value of the consideration transferred was $11.2 billion ($10.9 billion, net of cash acquired). In addition, $157 million in payments to Array employees for the fair value of previously unvested stock options was recognized as post-closing compensation expense and recorded in Restructuring charges and certain acquisition-related costs. |
Rx0000006 | Pfizer | 04/29/2024 | Nalbuphine Hydrochloride Injection for NovaPlus® Rx, 10 mg/mL, AMPUL (ML), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Nalbuphine Hydrochloride Injection for NovaPlus® Rx, 10 mg/mL, AMPUL (ML), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Nalbuphine Hydrochloride Injection Rx, 10 mg/mL, AMPUL (ML), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Nalbuphine Hydrochloride Injection Rx, 10 mg/mL, AMPUL (ML), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Nalbuphine Hydrochloride Injection Rx, 20 mg/mL, AMPUL (ML), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Nipent (pentostatin) Injection Rx, 10 mg, VIAL (EA), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Oxbryta® (voxelotor) Tablets Rx, 300 mg, TABLET FOR SUSPENSION, 60 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Oxbryta® (voxelotor) Tablets Rx, 300 mg, TABLET FOR SUSPENSION, 90 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Oxbryta® (voxelotor) Tablets Rx, 500 mg, TABLET, 90 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Panzyga® (immune globulin intravenous, human - ifas) Solution Rx, 10 g/100 mL Vial, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Panzyga® (immune globulin intravenous, human - ifas) Solution Rx, 2.5 g/25 mL Vial, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Panzyga® (immune globulin intravenous, human - ifas) Solution Rx, 20 g/200 mL Vial, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Panzyga® (immune globulin intravenous, human - ifas) Solution Rx, 30 g/300 mL Vial, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Panzyga® (immune globulin intravenous, human - ifas) Solution Rx, 5 g/50 mL Vial, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | PIPERACILLIN-TAZOBACTAM (piperacillin sodium/tazobactam sodium), 13.5 gram, VIAL (EA), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | PLEGISOL (cardioplegic solution), 1000mL, PLASTIC BAG, PERFUSION (ML), 12 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Potassium Chloride Concentrate Injection Rx, 2 mEq/mL, VIAL (ML), 10 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Potassium Chloride Concentrate Injection Rx, 2 mEq/mL, VIAL (ML), 5 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Prempro® (conjugated estrogens/medroxy progesterone acetate) Tablets Rx, 0.3 mg-1.5 mg, TABLET, 28 | ||||
Rx0000006 | Pfizer | 04/29/2024 | PREPIDIL (dinoprostone), 0.5 mg/3 gram, GEL WITH PREFILLED APPLICATOR (GRAM), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Sodium Bicarbonate Injection Rx, 4.2% (5mEq/10mL) per glass Abboject® syringe, 10 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Sodium Bicarbonate Injection Rx, 7.5% (44/6 mEq/50mL) per glass Abboject® syringe, 10 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Sodium Bicarbonate Injection Rx, 8.4% (10mEq/10mL) per glass vial Abboject® syringe, 10 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Sodium Bicarbonate Injection Rx, 8.4% (50mEq/50mL) per glass Abbotject® syringe, 10 | ||||
Rx0000006 | Pfizer | 04/29/2024 | SOLU-CORTEF (hydrocortisone sodium succinate) 500 mg/4 mL, VIAL (EA), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | SOLU-CORTEF (hydrocortisone sodium succinate), 100 mg, VIAL (EA), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | SOLU-CORTEF (hydrocortisone sodium succinate), 100 mg/2 mL, VIAL (EA), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | SOLU-CORTEF (hydrocortisone sodium succinate), 100 mg/2 mL, VIAL EA, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | SOLU-CORTEF (hydrocortisone sodium succinate), 250 mg/2 mL VIAL (EA), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | SOLU-CORTEF (hydrocortisone sodium succinate), 250 mg/2 mL, VIAL EA 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | SOLU-CORTEF(hydrocortisone sodium succinate), 1000 mg/8 mL, VIAL EA 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Solu-Medrol® (methylprednisolone sodium succinate) Sterile Powder for Injection Rx, 2 gram, VIAL (EA), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Somavert® (pegvisomant) Injection with Prefilled Diluent Syringe Rx, 10 mg, VIAL (EA), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Somavert® (pegvisomant) Injection with Prefilled Diluent Syringe Rx, 15 mg, VIAL (EA), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Somavert® (pegvisomant) Injection with Prefilled Diluent Syringe Rx, 20 mg, VIAL (EA), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Somavert® (pegvisomant) Injection with Prefilled Diluent Syringe Rx, 25 mg, VIAL (EA), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Somavert® (pegvisomant) Injection with Prefilled Diluent Syringe Rx, 30 mg, VIAL (EA), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Talzenna® (talazoparib) Rx, 0.25 mg, CAPSULE, 30 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Talzenna® (talazoparib) Rx, 1 mg, CAPSULE, 30 | ||||
Rx0000006 | Pfizer | 04/29/2024 | THAM (tromethamine), 36 mg/mL (0.3 M), INTRAVENOUS SOLUTION, 6 | ||||
Rx0000006 | Pfizer | 04/29/2024 | TPN ELECTROLYTES (multiple electrolyte additive) Solution Rx, 20 mL, VIAL (ML), 25 | ||||
Rx0000006 | Pfizer | 04/29/2024 | TRUMENBA (Neisseria meningitidis group B, lipidated fHBP recombinant), 120 mcg / 0.5 mL, SYRINGE (ML), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | TRUMENBA (Neisseria meningitidis group B, lipidated fHBP recombinant), 120 mcg/0.5 mL, SYRINGE (ML), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Verapamil Hydrochloride Injection Rx, 2.5 mg/mL (10 mg/4 mL) Ansyr Plastic Syringe, 10 | ||||
Rx0000006 | Pfizer | 04/29/2024 | VINCRISTINE SULFATE (vincristine sulfate), 1 mg/mL, VIAL (ML) 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | VINCRISTINE SULFATE (vincristine sulfate), 1 mg/mL, VIAL (ML) 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | VINCRISTINE SULFATE (vincristine sulfate), 1 mg/mL, VIAL ML, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | VINCRISTINE SULFATE (vincristine sulfate), 1 mg/mL, VIAL ML, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | VINCRISTINE SULFATE (vincristine sulfate), 2 mg/2 mL VIAL (ML), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | VINCRISTINE SULFATE (vincristine sulfate), 2 mg/2 mL VIAL (ML), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | VINCRISTINE SULFATE (vincristine sulfate), 2 mg/2 mL, VIAL (ML), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | VINCRISTINE SULFATE (vincristine sulfate), 2 mg/2 mL, VIAL (ML), 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | VIZIMPRO (dacomitinib), 15 mg, TABLET, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | VIZIMPRO (dacomitinib), 30 mg, TABLET, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | VIZIMPRO (dacomitinib), 45 mg, TABLET, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Vyndamax (tafamidis) Capsule Rx, 61 mg, CAPSULE, 30 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Vyndaqel® (tafamidis meglumine) Capsules Rx, 20 mg, CAPSULE, 120 | ||||
Rx0000006 | Pfizer | 04/29/2024 | XALKORI (crizotinib), 200 mg, CAPSULE, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | XALKORI (crizotinib), 250 mg, CAPSULE, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | XELJANZ (tofacitinib citrate), 10 mg, TABLET, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | XELJANZ (tofacitinib citrate), 5 mg, TABLET, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | XELJANZ XR (tofacitinib citrate), 11 mg, TABLET, EXTENDED RELEASE 24 HR, 1 | ||||
Rx0000006 | Pfizer | 04/29/2024 | XELJANZ XR (tofacitinib citrate), 22 mg, TABLET, EXTENDED RELEASE 24 HR, 30 | ||||
Rx0000006 | Pfizer | 04/29/2024 | Xeljanz® (tofacitinib ) Oral Solution Rx, 1 mg/mL, SOLUTION ORAL, 240 | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 10/17/2024 | (DIPHENHYDRAMINE HYDROCHLORIDE) DIPHENHYDRAMINE HYDROCHLORIDE 12.5mg/5mL Oral Elixir, 5mL Cup [Qty: 1] | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 10/17/2024 | DIPHENHYDRAMINE HYDROCHLORIDE (DIPHENHYDRAMINE HYDROCHLORIDE) 12.5mg/5mL Oral Elixir, 10mL Cup [Qty: 1] | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 10/17/2024 | DIPHENHYDRAMINE HYDROCHLORIDE (DIPHENHYDRAMINE HYDROCHLORIDE) 12.5mg/5mL Oral Elixir, 10mL Cup [Qty: 100] | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 10/17/2024 | DIPHENHYDRAMINE HYDROCHLORIDE (DIPHENHYDRAMINE HYDROCHLORIDE) 12.5mg/5mL Oral Elixir, 5mL Cup [Qty: 100] | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 10/17/2024 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN; HYDROCODONE BITARTRATE) 325mg/15mL;7.5mg/15mL Oral Solution, 5mL Cup [Qty: 1] | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 10/17/2024 | HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN; HYDROCODONE BITARTRATE) 325mg/15mL;7.5mg/15mL Oral Solution, 5mL Cup [Qty: 40] | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 04/02/2024 | Lactulose Oral Solution 10 GM/15ML - 473mL Bottle [Qty: 1] | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 04/02/2024 | Lactulose Oral Solution 10 GM/15ML. - 946mL Bottle [Qty: 1] | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 10/17/2024 | SODIUM CITRATE AND CITRIC ACID (SODIUM CITRATE; CITRIC ACID) 500-334mg/5mL Oral Solution, 15mL Cup [Qty: 1] | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 10/17/2024 | SODIUM CITRATE AND CITRIC ACID (SODIUM CITRATE; CITRIC ACID) 500-334mg/5mL Oral Solution, 15mL Cup [Qty: 100] | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 10/17/2024 | SODIUM CITRATE AND CITRIC ACID (SODIUM CITRATE; CITRIC ACID) 500-334mg/5mL Oral Solution, 30mL Cup [Qty: 1] | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 10/17/2024 | SODIUM CITRATE AND CITRIC ACID (SODIUM CITRATE; CITRIC ACID) 500-334mg/5mL Oral Solution, 30mL Cup [Qty: 100] | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 10/17/2024 | SULFAMETHOXAZOLE-TRIMETHOPRIM (SULFAMETHOXAZOLE; TRIMETHOPRIM) | ||||
Rx0000135 | Pharmaceutical Associates, Inc | 10/17/2024 | SULFAMETHOXAZOLE-TRIMETHOPRIM (SULFAMETHOXAZOLE; TRIMETHOPRIM) 200-40mg/5mL Oral Suspension, 20mL Cup [Qty: 40] | ||||
Rx0000319 | Pharmacosmos Therapeutics | 03/31/2024 | Monoferric (ferric derisomaltose) Injection 1000mg/10mL 1 unit vial | ||||
Rx0000410 | PharmaEssentia USA Corporation | 05/13/2024 | Besremi Subcutaneous Solution Prefilled Syringe 500 MCG/ML | ||||
Rx0000410 | PharmaEssentia USA Corporation | 03/31/2024 | Besremi Subcutaneous Solution Prefilled Syringe 500 MCG/ML, 1 1ML syringe per package | ||||
Rx0000469 | Pharming Healthcare Inc | 04/12/2024 | Ruconest 2100 U; Injection; Powder for Solution; 1 Carton | ||||
Rx0000469 | Pharming Healthcare Inc | 04/12/2024 | Ruconest C1 Esterase Inhibitor (Recombinant) 2100 UNIT Solution Reconstituted 1 EA UD | ||||
Rx0000589 | Prasco, LLC d/b/a Prasco Laboratories | 07/30/2024 | Spritam (levetiracetam) tablet, 1000mg, 6 x 10 | ||||
Rx0000589 | Prasco, LLC d/b/a Prasco Laboratories | 07/30/2024 | Spritam (levetiracetam) tablet, 250mg, 6 x 10 | ||||
Rx0000589 | Prasco, LLC d/b/a Prasco Laboratories | 07/30/2024 | Spritam (levetiracetam) tablet, 500mg, 6 x 10 | ||||
Rx0000589 | Prasco, LLC d/b/a Prasco Laboratories | 07/30/2024 | Spritam (levetiracetam) tablet, 750mg, 6 x 10 | ||||
Rx0000536 | Protega Pharmaceuticals, Inc. | 03/31/2024 | RoxyBond 15mg is formulated with inactive ingredients that make the tablet more difficult to manipulate for misuse and abuse even if the tablet is subjected to physical manipulation and/or chemical extraction. | ||||
Rx0000536 | Protega Pharmaceuticals, Inc. | 03/31/2024 | RoxyBond 30mg is formulated with inactive ingredients that make the tablet more difficult to manipulate for misuse and abuse even if the tablet is subjected to physical manipulation and/or chemical extraction. | ||||
Rx0000536 | Protega Pharmaceuticals, Inc. | 03/31/2024 | RoxyBond 5mg is formulated with inactive ingredients that make the tablet more difficult to manipulate for misuse and abuse even if the tablet is subjected to physical manipulation and/or chemical extraction. | ||||
Rx0000220 | Puma Biotechnology, Inc. | 03/31/2024 | Nerlynx Oral Tablet 40 mg, 133 tablet package | ||||
Rx0000220 | Puma Biotechnology, Inc. | 03/31/2024 | Nerlynx Oral Tablet 40 mg, 180 tablet package | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 10MG TABLETS 100S | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 10MG TABLETS HUD 20S | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 15MG TABLETS 100S | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 15MG TABLETS HUD 20S | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 20MG TABLETS 100S | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 20MG TABLETS HUD 20S | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 30MG TABLETS 100S | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 30MG TABLETS HUD 20S | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 40MG TABLETS 100S | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 40MG TABLETS HUD 20S | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 60MG TABLETS 100S | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 60MG TABLETS HUD 20S | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 80MG TABLETS 100S | ||||
Rx0000056 | Purdue Pharma LP | 04/23/2024 | OXYCONTIN 80MG TABLETS HUD 20S | ||||
Rx0000342 | PureTek Corporation | 07/16/2024 | Davimet with Fluoride 0.75mg, chewable multivitamin, Grape flavor, 30 tablets, Vit A, Vit C, Vit D3, Vit. E, Thiamin, Riboflavin, Niacin, Vit. B6, Folate, Vit. B12, Fluoride | ||||
Rx0000342 | PureTek Corporation | 07/16/2024 | Hydroxate Gel, gel, hydrocortisone 2%, 1oz | ||||
Rx0000342 | PureTek Corporation | 07/16/2024 | Hydroxym Cream, Anti-itch cream, hydrocortisone 2%, 1oz | ||||
Rx0000356 | Radius Health, Inc. | 03/31/2024 | TYMLOS 80 MCG Pen | ||||
Rx0000356 | Radius Health, Inc. | 03/31/2024 | TYMLOS 80 MCG Pen / Carton | ||||
Rx0000363 | Recordati Rare Diseases, inc. | 12/13/2024 | Sylvant Intravenous Solution Reconstituted 100 MG 1 Vial | ||||
Rx0000363 | Recordati Rare Diseases, inc. | 12/13/2024 | Sylvant Intravenous Solution Reconstituted 400 MG 1 Vial | ||||
Rx0000166 | Redhill Biopharma, Inc. | 04/22/2024 | Talicia, Amoxicillin-Rifabutin-Omeprazole Cap DR 250-12.5-10 MG, 84 Each, Unit-of-Use, Bottle | ||||
Rx0000166 | Redhill Biopharma, Inc. | 04/22/2024 | Talicia, Amoxicillin-Rifabutin-Omeprazole Cap DR 250-12.5-10 MG, 84 Each, Unit-of-Use, Bottle Qty 2 | ||||
Rx0000563 | Rhodes Pharmaceuticals LP | 07/16/2024 | Dronabinol Capsules 2.5mg 60s | ||||
Rx0000563 | Rhodes Pharmaceuticals LP | 07/16/2024 | Hydromorphone HCL 4mg Tablets 100s | ||||
Rx0000563 | Rhodes Pharmaceuticals LP | 07/16/2024 | Hydromorphone HCL 8mg Tablets 100s | ||||
Rx0000563 | Rhodes Pharmaceuticals LP | 04/23/2024 | Morphine Sulfate ER 15mg Tablets 100s | ||||
Rx0000563 | Rhodes Pharmaceuticals LP | 07/16/2024 | Oxycodone Hydrochloride 20mg Tablets 100s | ||||
Rx0000563 | Rhodes Pharmaceuticals LP | 07/16/2024 | Oxycodone Hydrochloride 30mg Tablets 100s | ||||
Rx0000239 | Rigel Pharmaceuticals, Inc. | 04/04/2024 | TAVALISSE TAB 100MG 60 TABS | ||||
Rx0000239 | Rigel Pharmaceuticals, Inc. | 04/04/2024 | TAVALISSE Tab 150MG 60 TABS | ||||
Rx0000158 | RISING PHARMA HOLDINGS, INC. | 04/05/2024 | METHIMAZOLE TAB 10 MG 100CT | ||||
Rx0000158 | RISING PHARMA HOLDINGS, INC. | 04/05/2024 | METHIMAZOLE TAB 5 MG 100CT | ||||
Rx0000095 | Salix Pharmaceuticals, Inc. | 04/28/2024 | COLAZAL® (balsalazide disodium) 750mg Capsules, 280ct BTL | ||||
Rx0000095 | Salix Pharmaceuticals, Inc. | 04/28/2024 | RELISTOR® (methylnaltrexone bromide) 12mg/0.6mL, vial | ||||
Rx0000095 | Salix Pharmaceuticals, Inc. | 04/28/2024 | RELISTOR® (methylnaltrexone bromide) PFS 12 mg/0.6mL, 7ct | ||||
Rx0000095 | Salix Pharmaceuticals, Inc. | 04/28/2024 | RELISTOR® (methylnaltrexone bromide) PFS 12 mg/0.6mL, vial | ||||
Rx0000095 | Salix Pharmaceuticals, Inc. | 04/28/2024 | RELISTOR® (methylnaltrexone bromide) PFS 8 mg/0.4mL, 7ct | ||||
Rx0000095 | Salix Pharmaceuticals, Inc. | 04/28/2024 | RELISTOR® (methylnaltrexone bromide) Tablets 150mg, 90ct | ||||
Rx0000095 | Salix Pharmaceuticals, Inc. | 04/28/2024 | Trulance® (plecanatide) 3mg Tablets, 30 | 03/01/2019 | Synergy Pharmaceuticals Inc. | Bausch Health acquired certain assets of Synergy Pharmaceuticals Inc. including Trulance in a transaction valued at approximately $200 million plus certain assumed liabilities. https://ir.bauschhealth.com/news-releases/2018/12-12-2018-113003808 | |
Rx0000095 | Salix Pharmaceuticals, Inc. | 04/28/2024 | XIFAXAN® (rifaximin) 550mg Tablets HUD 6 cards of 10, 60ct Card | ||||
Rx0000095 | Salix Pharmaceuticals, Inc. | 04/28/2024 | XIFAXAN® (rifaximin) 550mg Tablets, 60ct | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | CILOXAN OINTMENT 0.3% 3.5G 1EOIN US | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | HYCAMTIN 0.25MG 10HGC US | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | HYCAMTIN 1MG 10HGC US | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | HYCAMTIN 4MG 1LYVI US | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | LESCOL XL 80MG 30TAB US | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | LOTREL 10+20MG 100HGC BO US | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | LOTREL 10+40MG 100HGC BO US | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | LOTREL 5+10MG 100HGC BO US | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | LOTREL 5+20MG 100HGC BO US | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | RECLAST 5MG/100ML 1LIVI US | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | RITALIN IR 10MG 100TAB BO US | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | RITALIN IR 20MG 100TAB BO US | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | RITALIN IR 5MG 100TAB BO US | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | RITALIN LA 10MG 100PRCH US | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | RITALIN LA 20MG 100PRCH US | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | RITALIN LA 30MG 100PRCH US | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | RITALIN LA 40MG 100PRCH US | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | TRAVATAN Z SOL .004% 2.5ML LDP US | ||||
Rx0000027 | Sandoz Inc. | 04/02/2024 | TRAVATAN Z SOL .004% 5ML LDP US | ||||
Rx0000011 | Sanofi | 04/30/2024 | DUPIXENT (dupilumab) 100 mg/0.67 mL (0.67 mL/syringe) - 2 syringes | ||||
Rx0000011 | Sanofi | 04/30/2024 | DUPIXENT (dupilumab) 200 mg/1.14 mL (1.14 mL/pen) - 2 pens | ||||
Rx0000011 | Sanofi | 04/30/2024 | DUPIXENT (dupilumab) 200 mg/1.14 mL (1.14 mL/syringe) - 2 syringes | ||||
Rx0000011 | Sanofi | 04/30/2024 | DUPIXENT (dupilumab) 300 mg/2 mL (2 mL/pen) - 2 pens | ||||
Rx0000011 | Sanofi | 04/30/2024 | DUPIXENT (dupilumab) 300 mg/2 mL (2 mL/syringe) - 2 syringes | ||||
Rx0000011 | Sanofi | 10/30/2024 | Jevtana® (cabazitaxel) Injection Concentrate) 60mg vial, 1.5ml carton | ||||
Rx0000011 | Sanofi | 04/30/2024 | KEVZARA® (sarilumab) 150 mg/1.14 mL pen - carton of 2 pens | ||||
Rx0000011 | Sanofi | 04/30/2024 | KEVZARA® (sarilumab) 150 mg/1.14 mL syringe - carton of 2 syringes | ||||
Rx0000011 | Sanofi | 04/30/2024 | KEVZARA® (sarilumab) 200 mg/1.14 mL pen - carton of 2 pens | ||||
Rx0000011 | Sanofi | 04/30/2024 | KEVZARA® (sarilumab) 200 mg/1.14 mL syringe - carton of 2 syringes | ||||
Rx0000011 | Sanofi | 04/30/2024 | MenQuadfi® (Meningococcal tetanus conjugate vaccine)10 mcg/0.5 mL (0.5 mL dose/vial) - 5 vials | ||||
Rx0000011 | Sanofi | 10/30/2024 | Typhim Vi® (Typhoid vaccine) 0.5 mL (1-dose) syringe | ||||
Rx0000011 | Sanofi | 10/30/2024 | Typhim Vi® (Typhoid vaccine) 10 mL (0.5 mL dose) vial | ||||
Rx0000011 | Sanofi | 04/30/2024 | Typhim Vi® (Typhoid vaccine)25 mcg/0.5 mL (0.5 ml dose/10 mL vial) - 1 vial | ||||
Rx0000011 | Sanofi | 04/30/2024 | Typhim Vi® (Typhoid vaccine)25 mcg/0.5 mL (0.5 ml dose/syringe) - 1 syringe | ||||
Rx0000011 | Sanofi | 10/30/2024 | YF-VAX® (Yellow fever vaccine) 0.5 mL (1-dose) vial | ||||
Rx0000011 | Sanofi | 04/30/2024 | YF-VAX® (Yellow fever vaccine)10 exp4.74 unit/0.5 mL (0.5 mL dose/vial) - 5 vials | ||||
Rx0000092 | Santarus, Inc. | 04/28/2024 | CYCLOSET® (bromocriptine mesytate tablets) 0.8 mg tablets, 200 ct | ||||
Rx0000086 | Seagen, Inc. | 07/18/2024 | ADCETRIS, 50mg, single-dose vial, packaged singly | ||||
Rx0000086 | Seagen, Inc. | 04/26/2024 | PADCEV (enfortumab vedotin-ejfv) 20 mg lyophilized powder in a single-dose vial for reconstitution | ||||
Rx0000086 | Seagen, Inc. | 04/26/2024 | PADCEV (enfortumab vedotin-ejfv) 30 mg lyophilized powder in a single-dose vial for reconstitution | ||||
Rx0000086 | Seagen, Inc. | 04/26/2024 | TIVDAK (tisotumab vedotin-tftv) 40mg/vial, Lyophilized Powder in a single-dose vial for reconstitution | ||||
Rx0000086 | Seagen, Inc. | 10/31/2024 | TIVDAK (tisotumab vedotin-tftv) 40mg/vial, Lyophilized Powder in a single-dose vial for reconstitution | ||||
Rx0000028 | Servier Pharmaceuticals LLC | 04/24/2024 | Oncaspar Injection Solution 750 UNIT/ML, 5 ML, Unit-Dose, Vial | ||||
Rx0000028 | Servier Pharmaceuticals LLC | 04/24/2024 | Tibsovo Oral Tablet 250 MG, 60 Each, Bottle | 04/06/2021 | Agios Pharmaceuticals | ||
Rx0000175 | Sobi Inc | 04/12/2024 | KINERET (anakinra) 100 MG/0.67 ML SYRINGE. 7 syringes in 1 carton (.67 ML in 1 syringe). | ||||
Rx0000244 | Sprout Pharmaceuticals, Inc. | 09/09/2024 | ADDYI (FLIBANSERIN) 100mg Oral Tablet, 30ct Bottle - [Qty:1] | ||||
Rx0000005 | Sumitomo Pharma America, Inc. | 04/02/2024 | Aptiom 30 Oral Tablets 200 MG | ||||
Rx0000005 | Sumitomo Pharma America, Inc. | 04/02/2024 | Aptiom 30 Oral Tablets 400 MG | ||||
Rx0000005 | Sumitomo Pharma America, Inc. | 04/02/2024 | Aptiom 30 Oral Tablets 800 MG | ||||
Rx0000005 | Sumitomo Pharma America, Inc. | 04/02/2024 | Aptiom 60 Oral Tablets 600 MG | ||||
Rx0000165 | Supernus Pharmaceuticals, Inc. | 04/05/2024 | Oxtellar XR Oral Tablet Extended Release 24 Hour 150 MG Package Size 100 Package Qty 1 | ||||
Rx0000165 | Supernus Pharmaceuticals, Inc. | 04/05/2024 | Oxtellar XR Oral Tablet Extended Release 24 Hour 300 MG Package Size 100 Package Qty 1 | ||||
Rx0000165 | Supernus Pharmaceuticals, Inc. | 04/05/2024 | Oxtellar XR Oral Tablet Extended Release 24 Hour 600 MG Package Size 100 Package Qty 1 | ||||
Rx0000165 | Supernus Pharmaceuticals, Inc. | 04/05/2024 | Qelbree Oral Capsule Extended Release 24 Hour 100 MG Package Size 30 Package Qty 1 | ||||
Rx0000165 | Supernus Pharmaceuticals, Inc. | 04/05/2024 | Qelbree Oral Capsule Extended Release 24 Hour 150 MG Package Size 30 Package Qty 1 | ||||
Rx0000165 | Supernus Pharmaceuticals, Inc. | 04/05/2024 | Qelbree Oral Capsule Extended Release 24 Hour 200 MG Package Size 30 Package Qty 1 | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | ALUNBRIG 180 MG TABLET * 30 PACK | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 10/09/2024 | ALUNBRIG 180 MG TABLET * 30 PACK | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | ALUNBRIG 30 MG TABLET * 30 PACK | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 10/09/2024 | ALUNBRIG 30 MG TABLET * 30 PACK | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | ALUNBRIG 90 MG TABLET * 30 PACK | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 10/09/2024 | ALUNBRIG 90 MG TABLET * 30 PACK | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | ALUNBRIG 90 MG TABLET * 7 PACK | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 10/09/2024 | ALUNBRIG 90 MG TABLET * 7 PACK | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | ALUNBRIG INITIATION PACK - 7 CT 90 MG TABLET and 23 CT 180 MG TABLET - PER PACK | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 10/09/2024 | ALUNBRIG INITIATION PACK - 7 CT 90 MG TABLET and 23 CT 180 MG TABLET - PER PACK | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/15/2024 | Entyvio Intravenous Solution Reconstituted 300 MG | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | ICLUSIG 10 MG TABLET * 30 PACK | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 10/09/2024 | ICLUSIG 10 MG TABLET * 30 PACK | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | ICLUSIG 15 MG TABLET * 30 PACK | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 10/09/2024 | ICLUSIG 15 MG TABLET * 30 PACK | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | ICLUSIG 30 MG TABLET * 30 PACK | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 10/09/2024 | ICLUSIG 30 MG TABLET * 30 PACK | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | ICLUSIG 45 MG TABLET * 30 PACK | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 10/09/2024 | ICLUSIG 45 MG TABLET * 30 PACK | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | NINLARO 2.3 MG CAPSULE * 3 PACK | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | NINLARO 2.3 MG CAPSULE * SINGLE PACK | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | NINLARO 3.0 MG CAPSULE * 3 PACK | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | NINLARO 4.0 MG CAPSULE * 3 PACK | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | NINLARO 4.0 MG CAPSULE * SINGLE PACK | ||||
Rx0000105 | Takeda Pharmaceuticals America, Inc. | 04/26/2024 | NINLARO 3.0 MG CAPSULE * SINGLE PACK | ||||
Rx0000232 | TerSera Therapeutics LLC | 04/30/2024 | Xermelo Oral Tablet 250 MG, 84 Each, Unit-of-Use, Box | 09/08/2020 | Lexicon Pharmaceuticals, Inc | 159000000 | " Lexicon received approximately $159M in upfront payments and up to $65 million in future milestone payments plus mid-teens royalties on net sales of XERMELO for the treatment of biliary tract cancer." |
Rx0000232 | TerSera Therapeutics LLC | 04/30/2024 | Zoladex Subcutaneous Implant 10.8 MG, 1 Each, Unit-of-Use, Box | ||||
Rx0000232 | TerSera Therapeutics LLC | 10/30/2024 | Zoladex Subcutaneous Implant 10.8 MG, 1 Each, Unit-of-Use, Box | ||||
Rx0000232 | TerSera Therapeutics LLC | 04/30/2024 | Zoladex Subcutaneous Implant 3.6 MG, 1 Each, Unit-Dose, Syringe | ||||
Rx0000232 | TerSera Therapeutics LLC | 10/30/2024 | Zoladex Subcutaneous Implant 3.6 MG, 1 Each, Unit-Dose, Syringe | ||||
Rx0000302 | Tetraphase Pharmaceuticals | 04/24/2024 | Xerava Intravenous Solution Reconstituted 50 MG, 1 Each, Unit-Dose, Vial Qty 12 | ||||
Rx0000217 | Teva Neuroscience, Inc. | 04/24/2024 | AUSTEDO 12 MG TABLET 60 | ||||
Rx0000217 | Teva Neuroscience, Inc. | 04/24/2024 | AUSTEDO 6 MG TABLET 60 | ||||
Rx0000217 | Teva Neuroscience, Inc. | 04/24/2024 | AUSTEDO 9 MG TABLET 60 | ||||
Rx0000217 | Teva Neuroscience, Inc. | 04/24/2024 | AZILECT 0.5MG TABLET 30 | ||||
Rx0000217 | Teva Neuroscience, Inc. | 04/24/2024 | AZILECT 1MG TABLET 30 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | ADDERALL 10MG TABLET 100 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | ADDERALL 12.5MG TABLET 100 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | ADDERALL 15MG TABLET 100 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | ADDERALL 20MG TABLET 100 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | ADDERALL 30MG TABLET 100 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | ADDERALL 5MG TABLET 100 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | ADDERALL 7.5MG TABLET 100 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | ADIPEX-P TABLETS 37.5 MG 100 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | ADIPEX-P TABLETS 37.5 MG 30 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | AMRIX 15 MG CAPSULE ER 60 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | AMRIX 30 MG CAPSULE ER 60 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | FENTORA 100 MCG TABLET 28 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | FENTORA 200 MCG TABLET 28 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | FENTORA 400 MCG TABLET 28 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | FENTORA 600 MCG TABLET 28 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | FENTORA 800 MCG TABLET 28 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | FIORICET 50/300/40 MG CAPSULE 100 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | FIORICET 50/300/40/30 MG CAPSULE 100 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | GALZIN 25 MG CAPSULE 250 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | GALZIN 50 MG CAPSULE 250 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | NUVIGIL 150MG TABLET 30 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | NUVIGIL 200MG TABLET 30 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | NUVIGIL 250MG TABLET 30 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | NUVIGIL 50MG TABLET 30 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | PROGLYCEM 50MG/ML ORAL SUS 30ML | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | PROVIGIL 100MG TABLET 30 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | PROVIGIL 200MG TABLET 30 | ||||
Rx0000019 | Teva Pharmaceuticals USA | 10/17/2024 | SMX-TMP INJ 80MG-16MG/ML 10 X 10ML PRM | ||||
Rx0000019 | Teva Pharmaceuticals USA | 10/17/2024 | SMX-TMP INJ 80MG-16MG/ML 10 X 10ML PRM | ||||
Rx0000019 | Teva Pharmaceuticals USA | 04/24/2024 | TRISENOX VIAL 2 MG/ML 6 ML | ||||
Rx0000218 | Teva Respiratory, LLC | 04/24/2024 | QNASL PEDS Nasal Aerosol Solution 40 MCG/ACT 6.8GM | ||||
Rx0000218 | Teva Respiratory, LLC | 04/24/2024 | QNASL PLV Nasal Aerosol Solution 80 MCG/ACT | ||||
Rx0000219 | Teva Women's Health, Inc. | 04/24/2024 | TREXALL 10 MG TABLET 30 | ||||
Rx0000219 | Teva Women's Health, Inc. | 04/24/2024 | TREXALL 15 MG TABLET 30 | ||||
Rx0000219 | Teva Women's Health, Inc. | 04/24/2024 | TREXALL 5 MG TABLET 30 | ||||
Rx0000219 | Teva Women's Health, Inc. | 04/24/2024 | TREXALL 7.5 MG TABLET 30 | ||||
Rx0000134 | Therakos, Inc. | 04/30/2024 | UVADEX (Methoxsalen) STERILE SOLUTION, 20 mcg/ML, 12 - 10ml vials per carton | ||||
Rx0000395 | Travere Therapeutics, Inc. | 10/25/2024 | Filspari Oral Tablet 200 MG 30 tablets 1 bottle | ||||
Rx0000395 | Travere Therapeutics, Inc. | 10/25/2024 | Filspari Oral Tablet 400 MG 30 tablets 1 bottle | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | BRIVIACT 100MG 60 TABLETS | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | BRIVIACT 100MG UNIT DOSE CARTON OF 100 TABLETS | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | BRIVIACT 10MG 60 TABLETS | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | BRIVIACT 10MG ORAL SOLUTION-300ML | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | BRIVIACT 25MG 60 TABLETS | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | BRIVIACT 25MG UNIT DOSE CARTON OF 100 TABLETS | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | BRIVIACT 50MG 60 TABLETS | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | BRIVIACT 50MG UNIT DOSE CARTON OF 100 TABLETS | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | BRIVIACT 75MG 60 TABLETS | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | BRIVIACT IV INJECTION FOR INTRAVENOUS USE 50mg/5mL | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | CIMZIA LYOPHOLIZED POWDER FOR INJECTION, 2 X 200 MG VIALS | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | CIMZIA PRE-FILLED SYRINGE KIT, 2 X 200 MG/ML PRE-FILLED SYRINGES | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | CIMZIA PRE-FILLED SYRINGE STARTER KIT, 6 X 200 MG/ML PRE-FILLED SYRINGES | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | FINTEPLA 2.2MG/ML, 30ML | 03/07/2022 | Zogenix, Inc. | 1900000000 | |
Rx0000090 | UCB, Inc | 04/30/2024 | FINTEPLA 2.2MG/ML, 360ML | 03/07/2022 | Zogenix, Inc. | 1900000000 | |
Rx0000090 | UCB, Inc | 04/30/2024 | KEPPRA 1000MG-60 TABLETS | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | KEPPRA 250MG-120 TABLETS | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | KEPPRA 500 MG-120 TABLETS | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | KEPPRA 750MG-120 TABLETS | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | KEPPRA IV-1ML INJECTION FOR INTRAVENOUS USE 500mg5mL 10 VIALS | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | KEPPRA ORAL SOLUTION-100MG-473ML | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | KEPPRA XR (LEVETIRACETAM) 500MG-60 TABLETS | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | KEPPRA XR 750MG (LEVETIRACETAM)-60 TABLETS | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | NAYZILAM 5 MG NASAL SPRAY-0.2ML | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | NEUPRO 1MG/24HR-30 TRANSDERMAL SYSTEM | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | NEUPRO 2MG/24HR-30 TRANSDERMAL SYSTEM | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | NEUPRO 3MG/24HR-30 TRANSDERMAL SYSTEM | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | NEUPRO 4MG/24HR-30 TRANSDERMAL SYSTEM | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | NEUPRO 6MG/24HR-30 TRANSDERMAL SYSTEM | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | NEUPRO 8MG/24HR-30 TRANSDERMAL SYSTEM | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | VIMPAT 100MG UD-60 TABLETS | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | VIMPAT 100MG-60 TABLETS | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | VIMPAT 150MG UD-60 TABLETS | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | VIMPAT 150MG-60 TABLETS | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | VIMPAT 200MG UD-60 TABLETS | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | VIMPAT 200MG-60 TABLETS | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | VIMPAT 50MG UD-60 TABLETS | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | VIMPAT 50MG-60 TABLETS | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | VIMPAT INJECTION FOR INTRAVENOUS USE 200MG/20ML 10 VIALS | ||||
Rx0000090 | UCB, Inc | 04/30/2024 | VIMPAT ORAL SOLUTION 10MG-200ML | ||||
Rx0000262 | Ultragenyx Pharmaceuticals Inc. | 04/03/2024 | Dojolvi .96 g/mL Oral Liquid 1 Carton | ||||
Rx0000036 | United Therapeutics | 03/31/2024 | ORENITRAM ER .125 MG Oral Tablet 10 Pack | ||||
Rx0000036 | United Therapeutics | 03/31/2024 | ORENITRAM ER .125 MG Oral Tablet 100 Pack | ||||
Rx0000036 | United Therapeutics | 03/31/2024 | ORENITRAM ER .25 MG Oral Tablet 10 Pack | ||||
Rx0000036 | United Therapeutics | 03/31/2024 | ORENITRAM ER .25 MG Oral Tablet 100 Pack | ||||
Rx0000036 | United Therapeutics | 03/31/2024 | ORENITRAM ER 1 MG Oral Tablet 10 Pack | ||||
Rx0000036 | United Therapeutics | 03/31/2024 | ORENITRAM ER 1 MG Oral Tablet 100 Pack | ||||
Rx0000036 | United Therapeutics | 03/31/2024 | ORENITRAM ER 2.5 MG Oral Tablet 10 Pack | ||||
Rx0000036 | United Therapeutics | 03/31/2024 | ORENITRAM ER 2.5 MG Oral Tablet 100 Pack | ||||
Rx0000036 | United Therapeutics | 03/31/2024 | ORENITRAM ER 5 MG Oral Tablet 100 Pack | ||||
Rx0000036 | United Therapeutics | 03/31/2024 | ORENITRAM ER 5 MG Pack Oral Tablet 10 Pack | ||||
Rx0000036 | United Therapeutics | 03/31/2024 | Unituxin Intravenous Solution 17.5 MG/5ML 1 Vial in 1 Carton | ||||
Rx0000443 | USWM, LLC | 04/10/2024 | LUCEMYRA .18mg 36 Tablet | ||||
Rx0000443 | USWM, LLC | 04/10/2024 | LUCEMYRA .18mg 96 Tablet | ||||
Rx0000450 | Vericel Corporation | 10/23/2024 | MACI; (Autologous Cultured Chondrocytes on Porcine Collagen Membrane) 1 BAG in 1 BOX (69866-1030-5) > 1 BOTTLE, PLASTIC in 1 BAG (69866-1030-4) > 1 IMPLANT in 1 BOTTLE, PLASTIC (69866-1030-3) | ||||
Rx0000450 | Vericel Corporation | 10/23/2024 | MACI; (Autologous Cultured Chondrocytes on Porcine Collagen Membrane) 2 BAG in 1 BOX > 1 BOTTLE, PLASTIC in 1 BAG (69866-1030-7) > 1 IMPLANT in 1 BOTTLE, PLASTIC (69866-1030-6) | ||||
Rx0000155 | Vertical Pharmaceuticals, LLC | 04/24/2024 | Corvite 150 Oral Tablet - package size 30 | ||||
Rx0000155 | Vertical Pharmaceuticals, LLC | 04/24/2024 | Corvite FE package size 30 | ||||
Rx0000155 | Vertical Pharmaceuticals, LLC | 04/24/2024 | Dsuvia - sublingual sufentanil citrate tablet 30 mcg, package size 1 | 04/03/2023 | AcelRX Pharmaceuticals | We are unable to provide a number as the acquisition agreement between companies died not involve an up-front payment. The agreement involves other types of payments based on certain events. The information is not available to the public and should be considered as a trade secret. | |
Rx0000155 | Vertical Pharmaceuticals, LLC | 04/24/2024 | Dsuvia - sublingual sufentanil citrate tablet 30 mcg, package size 10 | 04/03/2023 | AcelRX Pharmaceuticals | We are unable to provide a number as the acquisition agreement between companies died not involve an up-front payment. The agreement involves other types of payments based on certain events. The information is not available to the public and should be considered as a trade secret. | |
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 10mg/10mg 30s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 10mg/20mg 30s-New NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 10mg/20mg 30s-Old NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 10mg/40mg 30s-New NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 10mg/40mg 30s-Old NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 10mg/80mg 30s-New NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 10mg/80mg 30s-Old NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 5mg/10mg 30s-New NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 5mg/10mg 30s-Old NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 5mg/20mg 30s-New NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 5mg/20mg 30s-Old NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 5mg/40mg 30s-New NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 5mg/40mg 30s-Old NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 5mg/80mg 30s-New NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Caduet Tabs 5mg/80mg 30s-Old NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Cardura Tabs 1mg 100s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Cardura Tabs 2mg 100s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Cardura Tabs 4mg 100s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Cardura Tabs 8mg 100s-New NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Cardura Tabs 8mg 100s-Old NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Cardura XL Tabs 4mg 30s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Cardura XL Tabs 8mg 30s-New NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Cardura XL Tabs 8mg 30s-Old NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Celebrex Caps 100mg 100s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Celebrex Caps 100mg 500s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Celebrex Caps 100mg UD100 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Celebrex Caps 200mg 100s-New NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Celebrex Caps 200mg 100s-Old NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Celebrex Caps 200mg 500s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Celebrex Caps 200mg UD100 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Celebrex Caps 400mg 60s-New NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Celebrex Caps 400mg 60s-Old NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Celebrex Caps 400mg UD100-New NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Celebrex Caps 400mg UD100-Old NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Celebrex Caps 50mg 60s-New NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Celebrex Caps 50mg 60s-Old NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Dilantin ER Caps 100mg 1000s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Dilantin ER Caps 100mg 100s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Dilantin ER Caps 100mg UD100 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Dilantin ER Caps 30mg 100s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Dilantin Infatabs 50mg 100s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Dilantin Infatabs 50mg UD100 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Dilantin-125 Oral Suspension 125mg/5mL 237mL | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Effexor XR Caps 150mg 30s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Effexor XR Caps 150mg 90s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Effexor XR Caps 37.5mg 30s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Effexor XR Caps 37.5mg 90s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Effexor XR Caps 75mg 30s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Effexor XR Caps 75mg 90s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Geodon Caps 20mg 60s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Geodon Caps 40mg 60s-New NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Geodon Caps 40mg 60s-Old NDC | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Geodon Caps 60mg 60s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Geodon Caps 80mg 60s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Geodon Injection 20mg/mL SDV 10PK | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Inspra Tabs 25mg 30s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Inspra Tabs 50mg 30s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica Caps 100mg 90s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica Caps 100mg UD100 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica Caps 150mg 90s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica Caps 150mg UD100 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica Caps 200mg 90s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica Caps 225mg 90s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica Caps 25mg 90s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica Caps 300mg 90s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica Caps 50mg 90s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica Caps 50mg UD100 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica Caps 75mg 90s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica Caps 75mg UD100 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica CR Tabs 165mg 30s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica CR Tabs 330mg 30s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Lyrica CR Tabs 82.5mg 30s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Neurontin Caps 100mg 100s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Neurontin Caps 300mg 100s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Neurontin Caps 400mg 100s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Neurontin Tabs 600mg 100s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Neurontin Tabs 800mg 100s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Nitrostat Sublingual Tabs 0.3mg 100s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Nitrostat Sublingual Tabs 0.4mg 100s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Nitrostat Sublingual Tabs 0.4mg 100s (Convenience Pack) | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Nitrostat Sublingual Tabs 0.6mg 100s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Norvasc Tabs 10mg 90s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Norvasc Tabs 10mg UD100 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Norvasc Tabs 2.5mg 90s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Norvasc Tabs 5mg 300s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Norvasc Tabs 5mg 90s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Norvasc Tabs 5mg UD100 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Relpax Tabs 20mg 6s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Relpax Tabs 40mg 12s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Relpax Tabs 40mg 6s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Revatio Injection 0.8mg/mL 12.5mL | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Revatio Tabs 20mg 90s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Xalatan Ophthalmic Drops 0.005% 2.5mL | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Xanax Tabs 0.25mg 100s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Xanax Tabs 0.25mg 500s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Xanax Tabs 0.5mg 100s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Xanax Tabs 0.5mg 500s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Xanax Tabs 1mg 100s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Xanax Tabs 1mg 500s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Xanax Tabs 2mg 100s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Xanax XR Tabs 0.5mg 60s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Xanax XR Tabs 1mg 60s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Xanax XR Tabs 2mg 60s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Xanax XR Tabs 3mg 60s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Zoloft Tabs 100mg 30s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Zoloft Tabs 100mg UD100 | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Zoloft Tabs 25mg 30s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Zoloft Tabs 50mg 30s | ||||
Rx0000502 | Viatris Specialty LLC | 04/30/2024 | Zoloft Tabs 50mg UD100 | ||||
Rx0000066 | ViiV Healthcare | 03/31/2024 | DOVATO TAB 50-300MG 30 Tablets per BOTTLE | ||||
Rx0000066 | ViiV Healthcare | 03/31/2024 | JULUCA TAB 50-25MG 30 Tablets per BOTTLE | ||||
Rx0000066 | ViiV Healthcare | 03/31/2024 | RUKOBIA TAB 600MG ER 60 Tablets per BOTTLE | ||||
Rx0000066 | ViiV Healthcare | 03/31/2024 | TIVICAY PD TAB 5MG 60 Tablets per BOTTLE | ||||
Rx0000066 | ViiV Healthcare | 03/31/2024 | TIVICAY TAB 50MG 30 Tablets per BOTTLE | ||||
Rx0000066 | ViiV Healthcare | 03/31/2024 | TRIUMEQ TAB 600-50-300MG 30 Tablets per BOTTLE | ||||
Rx0000223 | Woodward Pharma Services LLC | 03/31/2024 | Lovaza (omega-3-acid ethyl esters) Capsules, 1g, 120 CT | 02/16/2021 | GLAXO SMITH KLINE | ||
Rx0000380 | Xeris Pharmaceuticals, INC. | 03/31/2024 | Keveyis Oral Tablet 50 MG, | ||||
Rx0000380 | Xeris Pharmaceuticals, INC. | 03/31/2024 | Keveyis Oral Tablet 50 MG, Dichlorphenamide Tab 50 MG, 100 Each, Bottle | ||||
Rx0000380 | Xeris Pharmaceuticals, INC. | 10/09/2024 | Recorlev Oral Tablet 150 MG 50 per bottle | ||||
Rx0000163 | Zyla Life Sciences | 07/29/2024 | Sprix (ketorolac tromethamine) 15.75mg/1 Spray, 8 Sprays / Bottle (1 Bottle) | ||||
Rx0000163 | Zyla Life Sciences | 07/29/2024 | Sprix (ketorolac tromethamine) 15.75mg/1 Spray, 8 Sprays per Bottle (5 Bottles per Carton) | ||||
None | None | None | None |